PoliCheck Network
← Back to bills
H.R. 3037119th CongressReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Access to Breast Cancer Diagnosis Act of 2025

Introduced: Apr 28, 2025
Latest action: Apr 28, 2025

Latest Action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

1
Primary Sponsors
19
Cosponsors
2
Recorded Actions
0
Linked Votes

Plain-English AI Summary

What this bill means

Generated from the official bill text to make the legislation easier to understand.

Not Generated

A plain-English AI summary has not been generated for this bill yet.

Official Summary

Official legislative summary associated with this bill.

No official summary is currently available.

Primary Sponsors

Members listed as primary sponsors of this legislation.

Cosponsors

Members who joined this legislation as cosponsors.

Brian K. Fitzpatrick

Brian K. Fitzpatrick

Republican • Pennsylvania • District 1

Original Cosponsor

Apr 28, 2025

View profile →

Debbie Wasserman Schultz

Debbie Wasserman Schultz

Democrat • Florida • District 25

Original Cosponsor

Apr 28, 2025

View profile →

Paul Tonko

Paul Tonko

Democrat • New York • District 20

Aug 12, 2025

View profile →

Jennifer L. McClellan

Jennifer L. McClellan

Democrat • Virginia • District 4

Aug 12, 2025

View profile →

Michael Lawler

Michael Lawler

Republican • New York • District 17

Aug 22, 2025

View profile →

Scott H. Peters

Scott H. Peters

Democrat • California • District 50

Oct 3, 2025

View profile →

Lucy McBath

Lucy McBath

Democrat • Georgia • District 6

Nov 7, 2025

View profile →

Claudia Tenney

Claudia Tenney

Republican • New York • District 24

Nov 7, 2025

View profile →

Joe Neguse

Joe Neguse

Democrat • Colorado • District 2

Jan 12, 2026

View profile →

Lori Trahan

Lori Trahan

Democrat • Massachusetts • District 3

Jan 12, 2026

View profile →

Kim Schrier

Kim Schrier

Democrat • Washington • District 8

Apr 27, 2026

View profile →

Max L. Miller

Max L. Miller

Republican • Ohio • District 7

May 11, 2026

View profile →

Daniel S. Goldman

Daniel S. Goldman

Democrat • New York • District 10

Jun 2, 2026

View profile →

Donald G. Davis

Donald G. Davis

Democrat • North Carolina • District 1

Jun 2, 2026

View profile →

Haley M. Stevens

Haley M. Stevens

Democrat • Michigan • District 11

Jun 24, 2026

View profile →

Maggie Goodlander

Maggie Goodlander

Democrat • New Hampshire • District 2

Aug 24, 2026

View profile →

Shri Thanedar

Shri Thanedar

Democrat • Michigan • District 13

Aug 24, 2026

View profile →

Ted Lieu

Ted Lieu

Democrat • California • District 36

Aug 27, 2026

View profile →

Chuck Edwards

Chuck Edwards

Republican • North Carolina • District 11

Aug 31, 2026

View profile →

Recorded Actions

Official legislative actions recorded for this measure.

H11100Apr 28, 2025

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Official source ↗
Intro-HApr 28, 2025

Introduced in House

Official source ↗

Linked Votes

Roll-call votes associated with this legislation.

No roll-call votes are currently linked to this bill.

Lobbying Activity

Federal lobbying disclosures that explicitly identify H.R. 3037. These records show reported lobbying involving the legislation; they do not establish that every member of Congress, sponsor, or voter was personally contacted.

NOVARTIS, INC.

Registrant: FORBES-TATE

2nd Quarter (Apr 1 - June 30)
Jul 20, 2026

Reported lobbying issue

Health Issues: Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037 / S. 1500 Access to Breast Cancer Diagnosis Act of 2025. Medicare/Medicaid: Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to the 340b program; Issues related to S. 832 - EPIC Act of 2025. Trade (domestic/foreign): Issues related to prescription drug pricing; Issues related to pharmaceutical intellectual property; Issues related to international trade; Issues related to the 340b program. Budget/Appropriations: Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the 340b program. Copyright/Patent/Trademark: Issues related to prescription drug pricing and Intellectual Property (IP); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines; Issues related to the 340b program. Taxation/Internal Revenue Code: Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the 340b program.

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $50,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.

Registrant: HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.

2nd Quarter (Apr 1 - June 30)
Jul 20, 2026

Reported lobbying issue

Foreign Relations: HR 661 - MIRACLE Medical Technology Act of 2025 All provisions This bill requires the Secretary of Health and Human Services, in consultation with the Secretary of Commerce, the Council for Technology and Innovation of the Centers for Medicare & Medicaid Services, and the Commissioner of Food and Drugs, to carry out a program to facilitate and coordinate efforts between the United States and Israel to expand and enhance collaboration on the development and delivery of health care products and services. H.R. 764/S. 280 - Global Health, Empowerment and Rights Act All provisions This bill prohibits determining ineligibility of foreign nongovernmental organizations to receive assistance solely on the basis of health or medical services, including counseling and referral services, provided by such organizations with non-United States Government funds if such services do not violate the laws of the country in which they are being provided. H.R. 1229/S. 554 - United States-Israel Defense Partnership Act of 2025 All provisions This bill enhances bilateral defense cooperation between the United States and Israel. H.R. 2439/S. 3393 - Support UNFPA Funding Act All provisions This bill authorizes contributions to the United Nations Population Fund. H.R. 2609 - PEACE Act All provisions This bill promotes education and training to United States diplomatic personnel relating to the Abraham Accords and other normalization agreements with Israel. H.R. 4473 - BIRD Health Act of 2025 All provisions This bill directs the Secretary of Health and Human Services to establish a bilateral research and innovation program to facilitate and coordinate efforts between the United States and Israel in certain health-related areas. H.R. 4655 - United States-Israel PTSD Collaborative Research Act All provisions This bill directs the Secretary of Defense to carry out a grant program to increase cooperation on post-traumatic stress disorder research between the United States and Israel. H. Res. 525 - Affirming the role of the United States in eliminating sexual violence in conflict. All provisions This resolution affirms the role of the United States in eliminating sexual violence in conflict. S. Res. 410 - A resolution calling on the President to recognize a demilitarized State of Palestine, as consistent with international law and the principles of a two-state solution, alongside a secure State of Israel. All provisions This resolution calls on the President to recognize a demilitarized State of Palestine, as consistent with international law and the principles of a two-state solution, alongside a secure State of Israel. S. J. Res. 32, S. J. Res. 138 - A joint resolution providing for congressional disapproval of the proposed licensing of certain defense articles and services to Israel. All provisions. These resolutions provide for congressional disapproval of the proposed licensing of certain defense articles and services to Israel. H.R. 7018/S. 1521 - Stand with Israel Act of 2026 All provisions. This bill limits funding for United States participation in the United Nations if Israel is illegally expelled. H.R. 7540/S. 3855 - United States-Israel FUTURES Act of 2026 All provisions. This bill enhances bilateral defense cooperation between the United States and Israel. NEW: H.R. 9322/S. 4219 - Abraham Accords Defense Cooperation Act of 2026 All provisions This bill would require the Secretary of Defense to establish an initiative to bolster defense cooperation with Abraham Accords countries. H.R. 9147 - Abraham Accords Expansion Act of 2026 All provisions This bill supports efforts to expand the Abraham Accords to additional countries, including those in Central Asia and the Caucasus, and establish a special envoy in the US government to further advance peace and integration. S. 4681 - Optimizing Acquisition Strategies for Integrated Security (OASIS) in the Middle East Act All provisions This bill requires the Department of Defense to develop a coordinated air and missile defense acquisition strategy with Israel and Abraham Accords partners. Health Issues: H.R. 589 - FACE Act Repeal Act of 2025 All provisions This bill amends title 18, United States Code, to repeal prohibitions relating to freedom of access to clinic entrances. H.R. 3916/S. 2029 - My Body, My Data Act of 2025 All provisions This bill creates protections for the privacy of personal reproductive or sexual health information. H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025 All provisions This bill amends title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. H.R. 1909/S. 2621 - Preventing Maternal Deaths Reauthorization Act All provisions This bill amends the Public Health Service Act to reauthorize support for State-based maternal mortality review committees, to direct the Secretary of Health and Human Services to disseminate best practices on maternal mortality prevention to hospitals, State-based professional societies, and perinatal quality collaboratives. H.R. 4849/S. 2556 - Protecting Health Care and Lowering Costs Act of 2025 All provisions This bill will repeal health-related portions of An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14, and for other purposes. H.R. 4541/S. 2339 - EARLY Act Reauthorization of 2025 All provisions. This bill reauthorizes the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009. H.R. 3037/S. 1500 - Access to Breast Cancer Diagnosis Act of 2025 All provisions. This bill amends title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. H.R. 6182/S. 1410 - Find It Early Act All provisions. This bill would ensure all health insurance plans cover screening and diagnostic breast imaging with no cost-sharing, including mammograms, ultrasounds and breast ultrasounds, and MRIs. H.R. 2048/S. 3442 - Metastatic Breast Cancer Access to Care Act All provisions. This bill expedites payment of Social Security Disability Insurance (SSDI) benefits and eligibility for Medicare coverage for those with metastatic breast cancer (i.e., breast cancer that has spread to other sites in the body). H.R. 2381/S. 1866 - SCREENS for Cancer Act of 2025 All provisions. This bill amends the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2026 through 2030. H.R. 3501/S. 1799 - Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act All provisions. This bill amends title XVIII of the Social Security Act to provide for certain cognitive impairment detection in the Medicare annual wellness visit and initial preventive physical examination. H.R. 6130/S. 3267 - ASAP Act All provisions. This bill amends title XVIII of the Social Security Act to provide for Medicare coverage of blood-based dementia screening tests. H.R. 7417/S. 3944 - Womens Heart Health Expansion Act All provisions. This bill amends the Public Health Service Act to reauthorize the WISEWOMAN program. S. 3999 - Women Veterans Specialty Care Access Act All provisions. This bill requires the Secretary of Veterans Affairs to ensure that women veterans may schedule appointments for womens specialty care in the VA health system without requiring a referral. H.R. 6238/S. 3254 - NIH IMPROVE Act All provisions This bill instructs the director of the National Institutes of Health (NIH) to advance research to improve maternal health outcomes. H.R. 8839 - Lainie Jones Comprehensive Cancer Survivorship Act All provisions This bill addresses gaps in the full continuum of cancer care, including the transition to primary care, care navigation and workforce support. H.R. 9090/S. 4503 - Advancing Menopause Care and Mid-Life Womens Health Act All provisions This bill expands federal research, training, awareness and education efforts around menopause. Education: H.R. 768/S. 332 - Holocaust Education and Antisemitism Lessons Act All provisions This bill directs the U.S. Holocaust Memorial Museum to study and report on Holocaust education efforts in states, local educational agencies (LEAs), and public elementary and secondary schools. H.R. 5714 - October 7 Remembrance Education Act All provisions. This bill directs the United States Holocaust Memorial Museum to develop a curriculum for the study of antisemitism surrounding Hamas October 7, 2023, terrorist attacks against Israel. Homeland Security: H.R. 5645/S. 2947 - Pray Safe Act of 2025 All provisions. This bill establishes the Federal Clearinghouse on Safety and Best Practices for Nonprofit Organizations, Faith-based Organizations, and Houses of Worship within the Department of Homeland Security. H.R. 9211/S. 4576 - Jewish American Security Act All provisions, including Section Five that would increase federal funding for the Nonprofit Security Grant Program to $1 billion. Civil Rights/Civil Liberties: H.R. 1007/S. 558 Antisemitism Awareness Act of 2025 All provisions This bill provides for the consideration of a definition of antisemitism set forth by the International Holocaust Remembrance Alliance for the enforcement of Federal antidiscrimination laws concerning education programs or activities, and for other purposes. H.R. 15/S. 1503 - Equality Act All provisions This bill prohibits discrimination on the basis of sex, gender identity, and sexual orientation. H.R. 3691 - Commission to Study Acts of Antisemitism in the United States Act All provisions This bill establishes the Commission to Study Acts of Antisemitism in the United States to investigate the causes of antisemitism and provide policy recommendations to Congress and the President. H.R. 6857/S. 163 - Protecting Students on Campus Act of 2025 All provisions This bill requires the Department of Education (ED) and institutions of higher education (IHEs) participating in federal student aid programs to distribute information on how to report alleged violations of civil rights under Title VI of the Civil Rights Act of 1964. H.R. 8239 - SACRED Act All provisions This bill amends title 18, United States Code, to prohibit harassment of persons, within a distance of 100 feet or closer to such place of religious worship. H. Res. 1251 - Calling on elected officials and civil society leaders to counter antisemitism and educate the public on the contributions of the Jewish-American community. S. Res. 738 - Recognizing the significance of Jewish American Heritage Month and calling on elected officials and civil society leaders to counter antisemitism. All provisions. These resolutions recognize May 2026 as Jewish American Heritage Month and call on elected officials and civil society leaders to counter antisemitism. H.R. 9211/S. 4576 - Jewish American Security Act All provisions, including Section 4 that would increase protection for Jewish students civil rights by establishing a Title VI coordinator at the Department of Education to address antisemitism, increase funding for the Nonprofit Security Grant Program to $1 billion, and assess violent antisemitism and document and respond to antisemitic content on social media platforms. Medical/Disease Research/Clinical Labs: HR 2319/ - Women and Lung Cancer Research and Preventative Services Act of 2025 All provisions This bill requires a review of women and lung cancer. H.R. 2717/S. 1320 - Servicewomen and Veterans Menopause Research Act All provisions This bill directs the Secretary of Defense and the Secretary of Veterans Affairs to take certain steps regarding research related to menopause, perimenopause, or mid-life womens health. H.R. 7694 - Gwenns Law All provisions This bill directs the Department of Health and Human Services to carry out a public awareness campaign to improve womens participation in clinical research. Family issues/Abortion/Adoption: H.R. 999/S. 422 - Right to Contraception Act All provisions This bill would safeguard Americans right to access all forms of birth control and protect against federal and state efforts to restrict it. H.R. 1197/S. 1562 - PREEMIE Reauthorization Act of 2025 All provisions This bill reauthorizes the Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act through FY2029 and establishes actions by the Department of Health and Human Services (HHS) to address preterm birth (i.e., babies born before 37 weeks of pregnancy). The bill was enacted on February 2, 2026. H.R. 1878 - IVF Access and Affordability Act All provisions This bill introduces a tax credit for fertility treatments, capping at $20,000 annually, with provisions for joint filers, income-based reductions, and a five-year carryforward for unused credits, effective for taxable years post-enactment. H.R. 2049 - Access to Family Building Act All provisions This bill provides a statutory right to access assisted reproductive technology (e.g., in vitro fertilization). R. 2762/S. 1394 Expanding Access to Family Planning Act All provisions This bill provides enhanced funding for family planning services. S. 2035 Protect IVF Act All provisions This bill establishes statutory rights to choose to receive, provide, and cover fertility treatments. H.R. 12 - Womens Health Protection Act of 2025 All provisions This bill protects a persons ability to determine whether to continue or end a pregnancy, and to protect a health care providers ability to provide abortion services. H.R. 4888/S. 2671 - Reproductive Rights are Human Rights Act of 2025 All provisions This bill will amend the Foreign Assistance Act of 1961 to require a section on reproductive rights in the Annual Country Reports on Human Rights Practices. H.R. 4977/S. 141 - Connected MOM Act All provisions This bill identifies and address barriers to coverage of remote physiologic devices under State Medicaid programs to improve maternal and child health outcomes for pregnant and postpartum women. H.R. 6945 - Supporting Pregnant and Parenting Women and Families Act All provisions This bill amends part A of title IV of the Social Security Act to clarify the authority of States to use funds for pregnancy centers. Budget/Appropriations: H.R. 9310 - Department of Homeland Security Appropriations Act, 2027; H.R. 9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; H.R. 8595 - National Security, Department of State, and Related Programs Appropriations Act, 2027 Provisions for increased funding and staff for the Office of the Special Envoy to Monitor and Combat Antisemitism for FY 2027; funding for the Special Envoy for Holocaust Issues; increasing the authorized funding for the Nonprofit Security Grant Program; security and defense partnerships with Israel including US-Israel missile defense cooperation on Iron Dome and Davids Sling and Arrow defense systems; US-Israel Anti-Tunneling Cooperation; access to essential health care, including abortion, contraception, fertility, and gender-affirming medical care. These bills make appropriations for the fiscal year ending September 30, 2027. H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027 Provisions for increased funding for US-Israel and US-Abraham Accords partners cooperative programs; provisions to strengthen defense and defense technology cooperation; provisions to monitor and combat antisemitism. This bill authorizes appropriations for fiscal year 2027 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and other purposes. Intelligence: H.R. 5011 - Violent Antisemitism Threat Assessment Act All provisions This bill will require a report from the Secretary of Defense to the House and Senate Committees on Armed Services on the threat posed by violent antisemitism as a component of transnational extremist movements. H.R. 5681 - STOP HATE Act of 2025 All provisions. This bill requires the reporting of certain terms of service of social media companies for purposes of limiting the online presence of terrorist organizations. Insurance: H.R. 8119 - HOPE with Fertility Services Act All provisions. This bill requires group health plans that cover obstetrical services to also cover infertility diagnosis, treatment, and standard fertility preservation services. H.R. 1670/S. 797 - Family Building FEHB Fairness Act All provisions This bill adds a requirement for Federal employee health benefit plans to include assisted reproductive treatment benefits. H.R. 2557/S. 1231 - IVF for Military Families Act All provisions This bill amends title 10, United States Code, to provide fertility treatment under the TRICARE Program. H.R. 4611/S. 2377 - EACH Act of 2025 All provisions This bill aims to ensure affordable abortion coverage and care for every person. H.R. 4648/S. 2408 - Access to Fertility Treatment and Care Act All provisions This bill will require health insurance plans to provide coverage for fertility treatment. Law Enforcement/Crime/Criminal Justice: H.R. 2588/S. 3724 - Improving Reporting to Prevent Hate Act of 2025 All provisions. This bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to include certain reporting to the uniform crime reporting program. H.R. 9066 - Community-Based Approaches to Prevent and Address Hate Crimes Act of 2026All provisions This bill would authorize grant funding through the Department of Justice (DOJ) to support community organizations working to prevent and respond to hate crimes.

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $60,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC

Registrant: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.

2nd Quarter (Apr 1 - June 30)
Jul 20, 2026

Reported lobbying issue

Health Issues: Access to Care One Big Beautiful Bill, P.L. 119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Health Care Affordability Act, H.R.247, S.46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Association Health Plans Act, H.R.2528, S.1847. This bill would amend the Employee Retirement Income Security Act of 1974 to treat association health plans as employers. Self-Insurance Protection Act, H.R. 2571. This bill would amend the Employee Retirement Income Security Act of 1974 to exclude from the definition of health insurance coverage certain medical stop-loss insurance. Access to Breast Cancer Diagnosis Act, H.R. 3037/S.1500. To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. Women and Lung Cancer Research and Preventative Services Act of 2025, H.R.2319, S.1157. This bill requires the Department of Health and Human Services working with the Department of Defense, to conduct an interagency review to evaluate the status of and identify opportunities for research on women and lunch cancer preventative services. Safe Step Act, H.R. 5509, S. 2903. Bill would require an exceptions process for any medication step therapy protocol in commercial insurance plans. Bipartisan Premium Tax Credit Extension Act, H.R. 5145, Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. Common Ground for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. Medically Tailored Home-Delivered Meals Demonstration Pilot Act, H.R.5439, S.2834. The bill would create a pilot program in Medicare for beneficiaries with diet-related diseases to receive medically tailored meals to their own home. Womens Health and Cancer Rights Modernization Act of 2025, H.R.5813. This bill amends the Womens Health & Cancer Rights Act to require that commercial health plans provide coverage of breast or wall reconstruction provided as part of breast cancer treatment. HELP Copays Act, H.R. 6423, S. 864. Bill would apply financial assistance towards the cost-sharing requirements of health insurance plans. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Mobile Cancer Screening Act, H.R. 4417, S. 2927. The bill would award grants, contracts, or cooperative agreements for supporting new mobile cancer screening units to expand patient access to essential screening services in rural and underserved communities. Breast Cancer Research Stamp Reauthorization Act of 2026, H.R.8358, S.4318. This bill would allow the U.S. Postal Service to extend its authority to issue the Breast Cancer Research semipostal stamp for 10 more years to raise funding for breast cancer research. Recognizing April as Cancer Prevention and Early Detection Month, H.Res.1196. The resolution would uplift the national commitment to cancer prevention and early detection to reduce the cancer burden and improve health outcomes for all Americans. Womens Health and Cancer Rights Modernization Act of 2025, H.R.5813. This bill would require group health plans and health insurers offering group or individual health insurance coverage to cover specified breast or chest wall reconstruction services related to breast cancer treatment. Medical Records Access Fairness Act, H.R.7790. The bill would require health care providers to give patients free access to their medical records at least once a year. Knock Out Cancer Act (H.R. 3873, or KO Cancer Act). The will would boost National Cancer Institute funding by 25% annually for FY2026-2030 to match cancers mortality toll and direct a report on drug shortages. Health Disparities Screening for Communities to Receive Early and Equitable Needed Services (SCREENS for Cancer Act, H.R. 2381, S.1866. Reauthorizes the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2030 to provide the program greater flexibility in providing access to lifesaving screening, diagnostic, and treatment services and continue its innovative work aimed to reduce disparities and advance health equity in breast and cervical cancer. Education and Awareness Requires Learning Young (EARLY) Act, H.R. 4541, S. 2339. This bill would reauthorize the CDC program that supports young and high-risk women as well as their providers to better understand breast health. Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act, H.R. 1300, S. 297. Legislation to remove cost sharing of PSA testing for those at the highest risk of being diagnosed with prostate cancer. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Data Equity. Legislative and regulatory funding to support the collection of detailed demographic data toward reducing disparities in cancer prevention, detection, and treatment. Prevent HPV Cancer Act of 2025, H.R. 6561. This bill would create a national public awareness campaign to promote education and awareness of HPV and HPV-associated cancers and would increase funding for the NBCCED program to boost breast and cervical cancer screening. Health Equity and Accountability Act. This bill advances policies to reduce health disparities and improve cancer prevention, research, and care for underserved communities. Childhood Cancer Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act (STAR) Act. Continued implementation and funding of the Childhood Cancer STAR Act to promote the development of new, safer therapies for children with cancer. Our appropriations request includes $30 million for the Childhood Cancer STAR Act and $50 million for the Childhood Cancer Data Initiative. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Give Kids and Chance Act of 2025, P.L. 119-75. Legislation that would accelerate pediatric cancer treatments and expand access to live-saving therapies for children battling rare diseases, spur drug development for pediatric rare diseases, improve outcomes for patients, and close gaps in pediatric drug research. One Big Beautiful Bill, P.L. 119-21, Advocate to protect pediatric cancer patients in implementation of changes to Medicaid under the law. Quality of Life Palliative Care Palliative Care and Hospice Education and Training Act (PCHETA), S. 22870, H.R. 4425. Legislation to facilitate access to palliative care and coordinated care management. Palliative Care Research Funding. Funding to focus and expand national research programs in palliative care at the National Institutes of Health. Specifically, ACS CAN is working to include funding for palliative care research in the FY26 LHHS Appropriations bill. Lainie Jones Comprehensive Cancer Survivorship Act, H.R. 8839. The bill would create pathways to address the financial challenges of cancer survivorship and maintain patients access to the health services needed to address the long-term effects of cancer. Federal Health Care Programs Department of Defense Cancer Research Funding. Ensure continued funding for cancer research within the DOD's Congressionally Directed Medical Research Program. Clinical Trials Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for and remote access to trials. To amend the Internal Revenue Act of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Taxation/Internal Revenue Code: One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Issues regarding expanding the availability of the charitable deduction for non-itemizers. Issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for ancillary (non-medical) costs and remote access to trials. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Health Care Affordability Act, H.R. 247, S. 46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Bipartisan Premium Tax Credit Extension Act, H.R. 5145. Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. CommonGround for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. A bill to amend the Internal Revenue Code of 1986 to extend the temporary enhanced premium credits, S.2824. Bill would extend the enhanced ACA tax credits for two years. Charity Parity Act, H.R. 8783, S. 4511. The bill would allow taxpayers to make direct qualified charitable distributions (QCDs) from their employer sponsored retirement plans. Tobacco: Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments.; Issues relating to FDA regulation of flavors, electronic cigarettes and cigars. Strengthening Task Force Operations to Prevent Illicit Vaping Act (STOP Illicit Vaping Act), H.R.6845, / S.3569, Bill would codify and strengthen the federal multi-agency task force, led by the Department of Justice and Food and Drug Administration, to coordinate enforcement, information sharing, and strategy to combat the illegal importation, distribution, and sale of unauthorized e-cigarettes. Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance. Helping Tobacco Users Quit Act, S. 2064. This bill provides for coverage of certain tobacco cessation services, without cost-sharing, of diagnostic, therapy, and counseling services and pharmacotherapy, including prescription and nonprescription tobacco cessation agents, that are provided under medical supervision and in accordance with specified guidelines under Medicaid and Children's Health Insurance Program (CHIP). Budget/Appropriations: One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. FY26 Labor, Health, and Human Services funding provisions. ACS CAN advocated for full implementation of the law and for funding to be issued consistent with statute. FY27 House and Senate Labor, Health and Human Services legislation. ACS CAN advocates for increases in cancer research and prevention, including NIH, NCI, CDC DCPC, and OSH funding. FY25 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP and funding for the Initiative for Improving Native American Cancer Outcomes through NCIs coordination with NIMHD. FY27 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP. ACS CAN advocates for increases in programs that advance research for cancers include the Peer Reviewed Cancer Research Program (PRCRP). FY27 Interior Appropriations for Indian Health Services funding. ACS CAN advocates for increased funding for health with a focus on cancer funding. FY27 Agriculture and FDA Appropriations for issues related to drug shortages and tobacco. ACS CAN advocates for funding for the FDA, for provisions to address drug shortages, and on tobacco policy including issues related to the FDA regulation of flavors, electronic cigarettes, and cigars and cessation therapies as well as language to reduce drug shortages and fully implement FDORA. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. OMBs proposed Regulation for Federal Financial Assistance (May 2026). The changes in federal regulations would risk politicizing federal grant awards by empowering appointees to override scientific merit reviews, delaying cancer research progress, reducing transparency, and threatening NIH/CDC-funded breakthroughs that save lives. Medicare/Medicaid: One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Lung Cancer Screening and Prevention Act, H.R. 140. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Ensuring Access to Essential Providers Act, S.2793. Bill would require Medicare Advantage plans to cover items and services furnished by certain essential community providers. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Access to Genetic Counselor Services Act, H.R.6280. Bill would expand coverage of genetic counseling services under Medicare. Lung Cancer Screening and Prevention Act of 2025, H.R. 1406. This bill authorizes Medicare coverage of additional types of lung cancer screening tests that are approved by the FDA, regardless of whether they are recommended by the United States Preventive Services Task Force (USPSTF). Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance. Medical/Disease Research/Clinical Labs: Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment, including support for ancillary (non-medical) costs. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Asal Sayas National Strategy on Young Adult Cancers Act, S. 4717: Directs the NIH to develop a comprehensive national strategy to address the alarming rise of cancers in adults ages 18 to 49. American Cures Act, S. 4494. This bill would permanently fund several federal agencies and programs that perform biomedical research. Defense: Defense Appropriations. ACS CAN advocates for cancer research funding within CDMRP. Indian/Native American Affairs: Issues relating to Indian Health Services and the Congressional Native American Caucus. FY27 appropriations for the Indian Health Service. ACS CAN advocates for full funding for FY27 and advanced appropriations to ensure American Indians and Alaska Natives have access to quality and affordable health care services. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. FY27 appropriations for the Initiative for Improving Native American Cancer Outcomes under the NIMHD and NCI. ACS CAN advocates for the continuation of full funding for the program to support research, education, outreach, and clinical access related to cancer in Native American populations.

Government entities reported: Centers For Disease Control & Prevention (CDC) Centers For Medicare and Medicaid Services (CMS) Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES Natl Institutes of Health (NIH) SENATE Food & Drug Administration (FDA)

Reported filing-period amount: $1,240,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

GE HEALTHCARE TECHNOLOGIES INC.

Registrant: GE HEALTHCARE TECHNOLOGIES INC.

2nd Quarter (Apr 1 - June 30)
Jul 20, 2026

Reported lobbying issue

Health Issues: Issues impacting artificial intelligence. Issues impacting corporate taxation. Issues impacting funding for health care including government research. Issues impacting health care and public health. Issues impacting manufacturing. Issues impacting medical device and health care cybersecurity. Issues impacting medical device regulation. Issues impacting medical insurance coverage. Issues impacting medical research. Issues impacting Medicare coverage and reimbursement for medical technology and health care services. Issues impacting radiopharmacetucials. Issues impacting servicing and repair of medical devices. Issues impacting wireless spectrum. Issues impacting international trade and supply chains. Issues impacting Veterans health. Issues related to insurance coverage for breast cancer screening. Issues related to maternal health. Issues related to critical minerals. S. 1866/H.R. 2381, SCREENS for Cancer Act of 2025, all provisions. S. 2339/H.R. 4541, EARLY Act Reauthorization of 2025, all provisions. S. 1591, ARCA Act of 2025, provisions related to healthcare. S. 1399/H.R. 6197, Health Tech Investment Act, all provisions. PL 119-21, An act to provide for reconciliation pursuant to title II of H.Con.Res. 14, implementation of provisions related to healthcare. S. 1410/H.R. 6182, Find It Early Act, all provisions. S. 1500/H.R. 3037 Access to Breast Cancer Diagnosis Act, all provisions. S. 2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act 2026, provisions related to healthcare. H.R. 5304, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act 2026, provisions related to healthcare. H.R. 4121, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2026, provisions related to healthcare. S. 2256, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2026, provisions related to healthcare. H.R. 8800/S. 4784, National Defense Authorization Act for Fiscal Year 2027, provisions related to healthcare. H.R. 3838, Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026, provisions related to healthcare.

Government entities reported: Commerce, Dept of (DOC) Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES Office of Management & Budget (OMB) SENATE Treasury, Dept of U.S. Trade Representative (USTR)

Reported filing-period amount: $350,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.

Registrant: HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.

1st Quarter (Jan 1 - Mar 31)
Apr 21, 2026

Reported lobbying issue

Homeland Security: H.R. 5645/S. 2947 - Pray Safe Act of 2025 All provisions. This bill establishes the Federal Clearinghouse on Safety and Best Practices for Nonprofit Organizations, Faith-based Organizations, and Houses of Worship within the Department of Homeland Security. Insurance: H.R. 8119 - HOPE with Fertility Services Act All provisions. This bill requires group health plans that cover obstetrical services to also cover infertility diagnosis, treatment, and standard fertility preservation services. Law Enforcement/Crime/Criminal Justice: H.R. 2588/S. 3724 - Improving Reporting to Prevent Hate Act of 2025 All provisions. This bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to include certain reporting to the uniform crime reporting program. Foreign Relations: HR 661 - MIRACLE Medical Technology Act of 2025 All provisions This bill requires the Secretary of Health and Human Services, in consultation with the Secretary of Commerce, the Council for Technology and Innovation of the Centers for Medicare & Medicaid Services, and the Commissioner of Food and Drugs, to carry out a program to facilitate and coordinate efforts between the United States and Israel to expand and enhance collaboration on the development and delivery of health care products and services. H.R. 764/S. 280 - Global Health, Empowerment and Rights Act All provisions This bill prohibits determining ineligibility of foreign nongovernmental organizations to receive assistance solely on the basis of health or medical services, including counseling and referral services, provided by such organizations with non-United States Government funds if such services do not violate the laws of the country in which they are being provided. H.R. 1229/S. 554 - United States-Israel Defense Partnership Act of 2025 All provisions This bill enhances bilateral defense cooperation between the United States and Israel. H.R. 2439/ S.3393 - Support UNFPA Funding Act All provisions This bill authorizes contributions to the United Nations Population Fund. H.R. 2609 - PEACE Act All provisions This bill promotes education and training to United States diplomatic personnel relating to the Abraham Accords and other normalization agreements with Israel. H.R. 3565 - To provide for a limitation on the transfer of defense articles and defense services to Israel. All provisions This bill provides for a limitation on the transfer of defense articles and defense services to Israel. H.R. 4473 - BIRD Health Act of 2025 All provisions This bill directs the Secretary of Health and Human Services to establish a bilateral research and innovation program to facilitate and coordinate efforts between the United States and Israel in certain health-related areas. H.R. 4655 - United States-Israel PTSD Collaborative Research Act All provisions This bill directs the Secretary of Defense to carry out a grant program to increase cooperation on post-traumatic stress disorder research between the United States and Israel. H.Res. 525 - Affirming the role of the United States in eliminating sexual violence in conflict. All provisions This resolution affirms the role of the United States in eliminating sexual violence in conflict. S.Res. 410 - A resolution calling on the President to recognize a demilitarized State of Palestine, as consistent with international law and the principles of a two-state solution, alongside a secure State of Israel. All provisions This resolution calls on the President to recognize a demilitarized State of Palestine, as consistent with international law and the principles of a two-state solution, alongside a secure State of Israel. S.J.Res. 136, S.J.Res. 137, S.J.Res. 138 - A joint resolution providing for congressional disapproval of the proposed licensing of certain defense articles and services to Israel. All provisions. These resolutions provide for congressional disapproval of the proposed licensing of certain defense articles and services to Israel. H.R. 7018/S. 1521 - Stand with Israel Act of 2026 All provisions. This bill limits funding for United States participation in the United Nations if Israel is illegally expelled. H.R. 7540/S. 3855 - United States-Israel FUTURES Act of 2026 All provisions. This bill enhances bilateral defense cooperation between the United States and Israel. Health Issues: H.R. 589 - FACE Act Repeal Act of 2025 All provisions This bill amends title 18, United States Code, to repeal prohibitions relating to freedom of access to clinic entrances. H.R. 3916/S. 2029 - My Body, My Data Act of 2025 All provisions This bill creates protections for the privacy of personal reproductive or sexual health information. H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025 All provisions This bill amends title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. H.R. 1909/S. 2621 - Preventing Maternal Deaths Reauthorization Act All provisions This bill amends the Public Health Service Act to reauthorize support for State-based maternal mortality review committees, to direct the Secretary of Health and Human Services to disseminate best practices on maternal mortality prevention to hospitals, State-based professional societies, and perinatal quality collaboratives. H.R. 4849/S. 2556 - Protecting Health Care and Lowering Costs Act of 2025 All provisions This bill will repeal health-related portions of An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14, and for other purposes. H.R. 4541/S. 2339 - EARLY Act Reauthorization of 2025 All provisions. This bill reauthorizes the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009. H.R. 3037/S. 1500 - Access to Breast Cancer Diagnosis Act of 2025 All provisions. This bill amends title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. H.R. 6182/ S. 1410- Find It Early Act All provisions. This bill would ensure all health insurance plans cover screening and diagnostic breast imaging with no cost-sharing, including mammograms, ultrasounds and breast ultrasounds, and MRIs. H.R. 2048/S. 3442 - Metastatic Breast Cancer Access to Care Act All provisions. This bill expedites payment of Social Security Disability Insurance (SSDI) benefits and eligibility for Medicare coverage for those with metastatic breast cancer (i.e., breast cancer that has spread to other sites in the body). H.R. 2381/S. 1866 - SCREENS for Cancer Act of 2025 All provisions. This bill amends the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2026 through 2030. H.R. 3501/S. 1799 - Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act All provisions. This bill amends title XVIII of the Social Security Act to provide for certain cognitive impairment detection in the Medicare annual wellness visit and initial preventive physical examination. H.R. 6130/S. 3267 - ASAP Act All provisions. This bill amends title XVIII of the Social Security Act to provide for Medicare coverage of blood-based dementia screening tests. H.R. 7417/S. 3944 - Womens Heart Health Expansion Act All provisions. This bill amends the Public Health Service Act to reauthorize the WISEWOMAN program. S. 3999 - Women Veterans Specialty Care Access Act All provisions. This bill requires the Secretary of Veterans Affairs to ensure that women veterans may schedule appointments for womens specialty care under the laws administered by the Secretary without requiring a referral. Education: H.R. 768/S. 332 - Holocaust Education and Antisemitism Lessons Act All provisions This bill directs the U.S. Holocaust Memorial Museum to study and report on Holocaust education efforts in states, local educational agencies (LEAs), and public elementary and secondary schools. H.R. 5714 - October 7 Remembrance Education Act All provisions. This bill directs the United States Holocaust Memorial Museum to develop a curriculum for the study of antisemitism surrounding Hamas October 7, 2023, terrorist attacks against Israel. Civil Rights/Civil Liberties: H.R. 1007/S. 558 Antisemitism Awareness Act of 2025 All provisions This bill provides for the consideration of a definition of antisemitism set forth by the International Holocaust Remembrance Alliance for the enforcement of Federal antidiscrimination laws concerning education programs or activities, and for other purposes. H.R. 15/S. 1503 - Equality Act All provisions This bill prohibits discrimination on the basis of sex, gender identity, and sexual orientation. H.R. 3691 - Commission to Study Acts of Antisemitism in the United States Act All provisions This bill establishes the Commission to Study Acts of Antisemitism in the United States to investigate the causes of antisemitism and provide policy recommendations to Congress and the President. H.R. 6857/S. 163 - Protecting Students on Campus Act of 2025 All provisions This bill requires the Department of Education (ED) and institutions of higher education (IHEs) participating in federal student aid programs to distribute information on how to report alleged violations of civil rights under Title VI of the Civil Rights Act of 1964. Medical/Disease Research/Clinical Labs: HR 2319/ - Women and Lung Cancer Research and Preventative Services Act of 2025 All provisions This bill requires a review of women and lung cancer. H.R. 2717/S. 1320 - Servicewomen and Veterans Menopause Research Act All provisions This bill directs the Secretary of Defense and the Secretary of Veterans Affairs to take certain steps regarding research related to menopause, perimenopause, or mid-life womens health. Family issues/Abortion/Adoption: H.R. 999/S. 422 - Right to Contraception Act All provisions This bill would safeguard Americans right to access all forms of birth control and protect against federal and state efforts to restrict it. H.R. 1197/S. 1562 - PREEMIE Reauthorization Act of 2025 All provisions This bill reauthorizes the Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act through FY2029 and establishes actions by the Department of Health and Human Services (HHS) to address preterm birth (i.e., babies born before 37 weeks of pregnancy). H.R. 1670/S. 797 - Family Building FEHB Fairness Act All provisions This bill adds a requirement for Federal employee health benefit plans to include assisted reproductive treatment benefits. H.R. 1878 - IVF Access and Affordability Act All provisions This bill introduces a tax credit for fertility treatments, capping at $20,000 annually, with provisions for joint filers, income-based reductions, and a five-year carryforward for unused credits, effective for taxable years post-enactment. H.R. 2049 - Access to Family Building Act All provisions This bill provides a statutory right to access assisted reproductive technology (e.g., in vitro fertilization). H.R. 2557/S. 1231 - IVF for Military Families Act All provisions This bill amends title 10, United States Code, to provide fertility treatment under the TRICARE Program. H.R. 2762/S. 1394 Expanding Access to Family Planning Act All provisions This bill provides enhanced funding for family planning services. S. 2035 Protect IVF Act All provisions This bill establishes statutory rights to choose to receive, provide, and cover fertility treatments. H.R. 12 - Womens Health Protection Act of 2025 All provisions This bill protects a persons ability to determine whether to continue or end a pregnancy, and to protect a health care providers ability to provide abortion services. H.R. 4611/S. 2377 - EACH Act of 2025 All provisions This bill aims to ensure affordable abortion coverage and care for every person. H.R. 4648/S. 2408 - Access to Fertility Treatment and Care Act All provisions This bill will require health insurance plans to provide coverage for fertility treatment. H.R. 4888/S. 2671 - Reproductive Rights are Human Rights Act of 2025 All provisions This bill will amend the Foreign Assistance Act of 1961 to require a section on reproductive rights in the Annual Country Reports on Human Rights Practices. H.R. 4977/S. 141 - Connected MOM Act All provisions This bill identifies and address barriers to coverage of remote physiologic devices under State Medicaid programs to improve maternal and child health outcomes for pregnant and postpartum women. H.R. 6945 - Supporting Pregnant and Parenting Women and Families Act All provisions This bill amends part A of title IV of the Social Security Act to clarify the authority of States to use funds for pregnancy centers. Budget/Appropriations: H.R. 4213 - Department of Homeland Security Appropriations Act, 2026 Provisions related to increasing the authorized funding for the Nonprofit Security Grant Program This bill makes appropriations for the Department of Homeland Security for the fiscal year ending September 30, 2026. H.R. 7148 Consolidated Appropriations Act, 2026; H.R. 7006 Financial Services and General Government and National Security, Department of State, and Related Programs Appropriations Act, 2026; H.R. 7147 Further Additional Continuing Appropriations Act, 2026; H.R. 7744 Department of Homeland Security Appropriations Act, 2026 Provisions for increased funding and staff for the Office of the Special Envoy to Monitor and Combat Antisemitism for FY 2026; funding for the Special Envoy for Holocaust Issues; increasing the authorized funding for the Nonprofit Security Grant Program; security and defense partnerships with Israel including US-Israel missile defense cooperation on Iron Dome and Davids Sling and Arrow defense systems; US-Israel Anti-Tunneling Cooperation; access to essential health care, including abortion, contraception, fertility, and gender-affirming medical care. These bills make appropriations for the fiscal year ending September 30, 2026. Intelligence: H.R. 5011 - Violent Antisemitism Threat Assessment Act All provisions This bill will require a report from the Secretary of Defense to the House and Senate Committees on Armed Services on the threat posed by violent antisemitism as a component of transnational extremist movements. H.R. 5681 - STOP HATE Act of 2025 All provisions. This bill requires the reporting of certain terms of service of social media companies for purposes of limiting the online presence of terrorist organizations.

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $60,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

GE HEALTHCARE TECHNOLOGIES INC.

Registrant: GE HEALTHCARE TECHNOLOGIES INC.

1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026

Reported lobbying issue

Health Issues: Issues impacting artificial intelligence. Issues impacting corporate taxation. Issues impacting funding for health care including government research. Issues impacting health care and public health. Issues impacting manufacturing. Issues impacting medical device and health care cybersecurity. Issues impacting medical device regulation. Issues impacting medical insurance coverage. Issues impacting medical research. Issues impacting Medicare coverage and reimbursement for medical technology and health care services. Issues impacting radiopharmacetucials. Issues impacting servicing and repair of medical devices. Issues impacting wireless spectrum. Issues impacting international trade and supply chains. Issues impacting Veterans health. Issues related to insurance coverage for breast cancer screening. Issues related to maternal health. Issues related to critical minerals. S. 1866/H.R. 2381, SCREENS for Cancer Act of 2025, all provisions. S. 2339/H.R. 4541, EARLY Act Reauthorization of 2025, all provisions. S. 1591, ARCA Act of 2025, provisions related to healthcare. S. 1399/H.R. 6197, Health Tech Investment Act, all provisions. PL 119-21, An act to provide for reconciliation pursuant to title II of H.Con.Res. 14, implementation of provisions related to healthcare. S. 1410/H.R. 6182, Find It Early Act, all provisions. S. 1500/H.R. 3037 Access to Breast Cancer Diagnosis Act, all provisions. S. 2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act 2026, provisions related to healthcare. H.R. 5304, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act 2026, provisions related to healthcare. H.R. 4121, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2026, provisions related to healthcare. S. 2256, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2026, provisions related to healthcare. S. 2296, National Defense Authorization Act for Fiscal Year 2026, provisions related to healthcare. H.R. 3838, Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026, provisions related to healthcare.

Government entities reported: Commerce, Dept of (DOC) Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES Office of Management & Budget (OMB) SENATE Treasury, Dept of U.S. Trade Representative (USTR)

Reported filing-period amount: $700,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC

Registrant: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.

1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026

Reported lobbying issue

Health Issues: Access to Care One Big Beautiful Bill, P.L. 119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Health Care Affordability Act, H.R.247, S.46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Association Health Plans Act, H.R.2528, S.1847. This bill would amend the Employee Retirement Income Security Act of 1974 to treat association health plans as employers. Self-Insurance Protection Act, H.R. 2571. This bill would amend the Employee Retirement Income Security Act of 1974 to exclude from the definition of health insurance coverage certain medical stop-loss insurance. Access to Breast Cancer Diagnosis Act, H.R. 3037/S.1500. To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. Women and Lung Cancer Research and Preventative Services Act of 2025, H.R.2319, S.1157. This bill requires the Department of Health and Human Services working with the Department of Defense, to conduct an interagency review to evaluate the status of and identify opportunities for research on women and lunch cancer preventative services. Safe Step Act, H.R. 5509, S. 2903. Bill would require an exceptions process for any medication step therapy protocol in commercial insurance plans. Bipartisan Premium Tax Credit Extension Act, H.R. 5145, Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. Common Ground for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. Medically Tailored Home-Delivered Meals Demonstration Pilot Act, H.R.5439, S.2834. The bill would create a pilot program in Medicare for beneficiaries with diet-related diseases to receive medically tailored meals to their own home. Womens Health and Cancer Rights Modernization Act of 2025, H.R.5813. This bill amends the Womens Health & Cancer Rights Act to require that commercial health plans provide coverage of breast or wall reconstruction provided as part of breast cancer treatment. HELP Copays Act, H.R. 6423, S. 864. Bill would apply financial assistance towards the cost-sharing requirements of health insurance plans. Health Disparities Nancy Gardner Sewell Medicare Early Detection Screening Coverage Act, P.L. 119-75. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown. Screening for Communities to Receive Early and Equitable Needed Services (SCREENS for Cancer Act, H.R. 2381, S.1866. Reauthorizes the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2030 to provide the program greater flexibility in providing access to lifesaving screening, diagnostic, and treatment services and continue its innovative work aimed to reduce disparities and advance health equity in breast and cervical cancer. Education and Awareness Requires Learning Young (EARLY) Act, H.R. 4541, S. 2339. This bill would reauthorize the CDC program that supports young and high-risk women as well as their providers to better understand breast health. Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act, H.R. 1300, S. 297. Legislation to remove cost sharing of PSA testing for those at the highest risk of being diagnosed with prostate cancer. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Data Equity. Legislative and regulatory funding to support the collection of detailed demographic data toward reducing disparities in cancer prevention, detection, and treatment. Prevent HPV Cancer Act of 2025, H.R. 6561. This bill would create a national public awareness campaign to promote education and awareness of HPV and HPV-associated cancers and would increase funding for the NBCCED program to boost breast and cervical cancer screening. Childhood Cancer Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act (STAR) Act. Continued implementation and funding of the Childhood Cancer STAR Act to promote the development of new, safer therapies for children with cancer. Our appropriations request includes $30 million for the Childhood Cancer STAR Act and $50 million for the Childhood Cancer Data Initiative. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Give Kids and Chance Act of 2025, P.L. 119-75. Legislation that would accelerate pediatric cancer treatments and expand access to live-saving therapies for children battling rare diseases, spur drug development for pediatric rare diseases, improve outcomes for patients, and close gaps in pediatric drug research. One Big Beautiful Bill, P.L. 119-21, Advocate to protect pediatric cancer patients in implementation of changes to Medicaid under the law. Quality of Life Palliative Care Palliative Care and Hospice Education and Training Act (PCHETA), S. 22870, H.R. 4425. Legislation to facilitate access to palliative care and coordinated care management. Palliative Care Research Funding. Funding to focus and expand national research programs in palliative care at the National Institutes of Health. Specifically, ACS CAN is working to include funding for palliative care research in the FY26 LHHS Appropriations bill. Federal Health Care Programs Department of Defense Cancer Research Funding. Ensure continued funding for cancer research within the DOD's Congressionally Directed Medical Research Program. Clinical Trials Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for and remote access to trials. To amend the Internal Revenue Act of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Taxation/Internal Revenue Code: One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Issues regarding expanding the availability of the charitable deduction for non-itemizers. Issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for ancillary (non-medical) costs and remote access to trials. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Health Care Affordability Act, H.R. 247, S. 46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Bipartisan Premium Tax Credit Extension Act, H.R. 5145. Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. CommonGround for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. A bill to amend the Internal Revenue Code of 1986 to extend the temporary enhanced premium credits, S.2824. Bill would extend the enhanced ACA tax credits for two years. Tobacco: Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments.; Issues relating to FDA regulation of flavors, electronic cigarettes and cigars. Strengthening Task Force Operations to Prevent Illicit Vaping Act (STOP Illicit Vaping Act), H.R.6845, / S.3569, Bill would codify and strengthen the federal multi-agency task force, led by the Department of Justice and Food and Drug Administration, to coordinate enforcement, information sharing, and strategy to combat the illegal importation, distribution, and sale of unauthorized e-cigarettes. Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance. Helping Tobacco Users Quit Act, S. 2064. This bill provides for coverage of certain tobacco cessation services, without cost-sharing, of diagnostic, therapy, and counseling services and pharmacotherapy, including prescription and nonprescription tobacco cessation agents, that are provided under medical supervision and in accordance with specified guidelines under Medicaid and Children's Health Insurance Program (CHIP). Budget/Appropriations: One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. FY26 Labor, Health, and Human Services funding provisions. ACS CAN advocated for full implementation of the law and for funding to be issued consistent with statute. FY27 House and Senate Labor, Health and Human Services legislation. ACS CAN advocates for increases in cancer research and prevention, including NIH, NCI, CDC DCPC, and OSH funding. FY25 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP and funding for the Initiative for Improving Native American Cancer Outcomes through NCIs coordination with NIMHD. FY27 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP. ACS CAN advocates for increases in programs that advance research for cancers include the Peer Reviewed Cancer Research Program (PRCRP). FY27 Interior Appropriations for Indian Health Services funding. ACS CAN advocates for increased funding for health with a focus on cancer funding. FY27 Agriculture and FDA Appropriations for issues related to drug shortages and tobacco. ACS CAN advocates for funding for the FDA, for provisions to address drug shortages, and on tobacco policy including issues related to the FDA regulation of flavors, electronic cigarettes, and cigars and cessation therapies as well as language to reduce drug shortages and fully implement FDORA. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. Medicare/Medicaid: One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act, P.L. 119-75. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown. Lung Cancer Screening and Prevention Act, H.R. 140. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Ensuring Access to Essential Providers Act, S.2793. Bill would require Medicare Advantage plans to cover items and services furnished by certain essential community providers. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Access to Genetic Counselor Services Act, H.R.6280. Bill would expand coverage of genetic counseling services under Medicare. Lung Cancer Screening and Prevention Act of 2025, H.R. 1406. This bill authorizes Medicare coverage of additional types of lung cancer screening tests that are approved by the FDA, regardless of whether they are recommended by the United States Preventive Services Task Force (USPSTF). Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance. Medical/Disease Research/Clinical Labs: Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment, including support for ancillary (non-medical) costs. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act, P.L. 119-75. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown. Defense: Defense Appropriations. ACS CAN advocates for cancer research funding within CDMRP. Indian/Native American Affairs: Issues relating to Indian Health Services and the Congressional Native American Caucus. FY27 appropriations for the Indian Health Service. ACS CAN advocates for full funding for FY27 and advanced appropriations to ensure American Indians and Alaska Natives have access to quality and affordable health care services. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. FY27 appropriations for the Initiative for Improving Native American Cancer Outcomes under the NIMHD and NCI. ACS CAN advocates for the continuation of full funding for the program to support research, education, outreach, and clinical access related to cancer in Native American populations.

Government entities reported: Centers For Disease Control & Prevention (CDC) Centers For Medicare and Medicaid Services (CMS) Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES Natl Institutes of Health (NIH) SENATE Food & Drug Administration (FDA)

Reported filing-period amount: $2,300,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

NOVARTIS, INC.

Registrant: FORBES-TATE

1st Quarter (Jan 1 - Mar 31)
Apr 18, 2026

Reported lobbying issue

Taxation/Internal Revenue Code: Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the 340b program. Health Issues: Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037 / S. 1500 Access to Breast Cancer Diagnostic Act of 2025. Medicare/Medicaid: Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to the 340b program; Issues related to S. 832 - EPIC Act of 2025. Trade (domestic/foreign): Issues related to prescription drug pricing; Issues related to pharmaceutical intellectual property; Issues related to international trade; Issues related to the 340b program. Budget/Appropriations: Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the 340b program. Copyright/Patent/Trademark: Issues related to prescription drug pricing and Intellectual Property (IP); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines; Issues related to the 340b program.

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $50,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

GE HEALTHCARE TECHNOLOGIES INC.

Registrant: GE HEALTHCARE TECHNOLOGIES INC.

4th Quarter (Oct 1 - Dec 31)
Jan 20, 2026

Reported lobbying issue

Health Issues: Issues impacting artificial intelligence. Issues impacting corporate taxation. Issues impacting funding for health care including government research. Issues impacting health care and public health. Issues impacting manufacturing. Issues impacting medical device and health care cybersecurity. Issues impacting medical device regulation. Issues impacting medical insurance coverage. Issues impacting medical research. Issues impacting Medicare coverage and reimbursement for medical technology and health care services. Issues impacting radiopharmacetucials. Issues impacting servicing and repair of medical devices. Issues impacting wireless spectrum. Issues impacting international trade and supply chains. Issues impacting Veterans health. Issues related to insurance coverage for breast cancer screening. Issues related to maternal health. Issues related to critical minerals. S. 1399/H.R. 6197, Health Tech Investment Act, all provisions. PL 119-21, An act to provide for reconciliation pursuant to title II of H.Con.Res. 14, implementation of provisions related to healthcare. S. 1410/H.R. 6182, Find It Early Act, all provisions. S. 1500/H.R. 3037 Access to Breast Cancer Diagnosis Act, all provisions. S. 2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act 2026, provisions related to healthcare. H.R. 5304, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act 2026, provisions related to healthcare. H.R. 4121, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2026, provisions related to healthcare. S. 2256, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2026, provisions related to healthcare. S. 2296, National Defense Authorization Act for Fiscal Year 2026, provisions related to healthcare. H.R. 3838, Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026, provisions related to healthcare.

Government entities reported: Commerce, Dept of (DOC) Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES Office of Management & Budget (OMB) SENATE Treasury, Dept of U.S. Trade Representative (USTR)

Reported filing-period amount: $380,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC

Registrant: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.

4th Quarter (Oct 1 - Dec 31)
Jan 20, 2026

Reported lobbying issue

Health Issues: Access to Care One Big Beautiful Bill, P.L. 119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Health Care Affordability Act, H.R.247, S.46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Association Health Plans Act, H.R.2528, S.1847. This bill would amend the Employee Retirement Income Security Act of 1974 to treat association health plans as employers. Self-Insurance Protection Act, H.R. 2571. This bill would amend the Employee Retirement Income Security Act of 1974 to exclude from the definition of health insurance coverage certain medical stop-loss insurance. Access to Breast Cancer Diagnosis Act, H.R. 3037/S.1500. To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. Women and Lung Cancer Research and Preventative Services Act of 2025, H.R.2319, S.1157. This bill requires the Department of Health and Human Services working with the Department of Defense, to conduct an interagency review to evaluate the status of and identify opportunities for research on women and lunch cancer preventative services. Education and Awareness Requires Learning (EARLY) Act, H.R. 4541, S. 2339. This bill would reauthorize the CDC program that supports young and high-risk women as well as their providers to better understand breast health. Safe Step Act, H.R. 5509, S. 2903. Bill would require an exceptions process for any medication step therapy protocol in commercial insurance plans. Bipartisan Premium Tax Credit Extension Act, H.R. 5145, Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. Common Ground for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. Medically Tailored Home-Delivered Meals Demonstration Pilot Act, H.R.5439, S.2834. The bill would create a pilot program in Medicare for beneficiaries with diet-related diseases to receive medically tailored meals to their own home. Health Disparities Nancy Gardner Sewell Medicare Early Detection Screening Coverage Act, H.R. 842, S. 339. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown. Screening for Communities to Receive Early and Equitable Needed Services (SCREENS for Cancer Act, H.R. 2381, S.1866. Reauthorizes the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2030 to provide the program greater flexibility in providing access to lifesaving screening, diagnostic, and treatment services and continue its innovative work aimed to reduce disparities and advance health equity in breast and cervical cancer. Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act, H.R. 1300, S. 297. Legislation to remove cost sharing of PSA testing for those at the highest risk of being diagnosed with prostate cancer. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Data Equity. Legislative and regulatory funding to support the collection of detailed demographic data toward reducing disparities in cancer prevention, detection, and treatment. Equality Act, H.R. 15, S. 1503. This bill prohibits discrimination based on sex, sexual orientation, or gender identity with respect to businesses, employment, housing, federally funded programs, and other settings. Henrietta Lacks Congressional Gold Medal Act, H.R. 3498, S.1893. Legislation to award posthumously a Congressional Gold Medal to Henrietta Lacks, in recognition of her immortal cells which have made invaluable contributions to global health, scientific research, our quality of life, and patients' rights. Prevent HPV Cancer Act of 2025, H.R. 6561. This bill would create a national public awareness campaign to promote education and awareness of HPV and HPV-associated cancers and would increase funding for the NBCCED program to boost breast and cervical cancer screening. Childhood Cancer Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act (STAR) Act. Continued implementation and funding of the Childhood Cancer STAR Act to promote the development of new, safer therapies for children with cancer. Our appropriations request includes $30 million for the Childhood Cancer STAR Act and $50 million for the Childhood Cancer Data Initiative. Accelerating Kids Access to Care Act, S.752, H.R.1509. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Give Kids and Chance Act of 2025, S.932, S. 3302, H.R. 1262. Legislation that would accelerate pediatric cancer treatments and expand access to live-saving therapies for children battling rare diseases, spur drug development for pediatric rare diseases, improve outcomes for patients, and close gaps in pediatric drug research. One Big Beautiful Bill, P.L. 119-21, Advocate to protect pediatric cancer patients in implementation of changes to Medicaid under the law. Quality of Life Palliative Care Palliative Care and Hospice Education and Training Act (PCHETA), S. 22870, H.R. 4425. Legislation to facilitate access to palliative care and coordinated care management. Palliative Care Research Funding. Funding to focus and expand national research programs in palliative care at the National Institutes of Health. Specifically, ACS CAN is working to include funding for palliative care research in the FY26 LHHS Appropriations bill. Federal Health Care Programs Department of Defense Cancer Research Funding. Ensure continued funding for cancer research within the DOD's Congressionally Directed Medical Research Program. Clinical Trials Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment. Barriers may include ancillary (non-medical) costs, such as transportation and lodging, and remote access to trials, particularly for people who are underrepresented, including certain racial and ethnic groups, older adults, rural residents, and those with limited incomes. To amend the Internal Revenue Act of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Taxation/Internal Revenue Code: One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Issues regarding expanding the availability of the charitable deduction for non-itemizers. Issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment. Barriers may include ancillary (non-medical) costs, such as transportation and lodging, and remote access to trials, particularly for people who are underrepresented, including certain racial and ethnic groups, older adults, rural residents, and those with limited incomes. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Health Care Affordability Act, H.R. 247, S. 46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Bipartisan Premium Tax Credit Extension Act, H.R. 5145. Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. CommonGround for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. A bill to amend the Internal Revenue Code of 1986 to extend the temporary enhanced premium credits, S.2824. Bill would extend the enhanced ACA tax credits for two years. Tobacco: Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments.; Issues relating to FDA regulation of flavors, electronic cigarettes and cigars. Strengthening Task Force Operations to Prevent Illicit Vaping Act (STOP Illicit Vaping Act), H.R.6845, / S.3569, Bill would codify and strengthen the federal multi-agency task force, led by the Department of Justice and Food and Drug Administration, to coordinate enforcement, information sharing, and strategy to combat the illegal importation, distribution, and sale of unauthorized e-cigarettes. Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance. Budget/Appropriations: One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. FY25 Labor, Health, and Human Services CR provisions. ACS CAN advocated for full implementation of the law and for funding to be issued consistent with statute. FY26 House and Senate Labor, Health and Human Services legislation. ACS CAN advocates for increases in cancer research and prevention, including NIH, NCI, CDC DCPC, and OSH funding. FY25 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP and funding for the Initiative for Improving Native American Cancer Outcomes through NCIs coordination with NIMHD. FY26 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP. ACS CAN advocates for increases in programs that advance research for cancers include the Peer Reviewed Cancer Research Program (PRCRP). FY26 Interior Appropriations for Indian Health Services funding. ACS CAN advocates for increased funding for health with a focus on cancer funding. FY26 Agriculture and FDA Appropriations for issues related to drug shortages and tobacco. ACS CAN advocates for funding for the FDA, for provisions to address drug shortages, and on tobacco policy including issues related to the FDA regulation of flavors, electronic cigarettes, and cigars. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. Medicare/Medicaid: One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act, H.R. 842, S.339. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown. Lung Cancer Screening and Prevention Act, H.R. 140. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Accelerating Kids Access to Care Act, S.752, H.R. 150. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Ensuring Access to Essential Providers Act, S.2793. Bill would require Medicare Advantage plans to cover items and services furnished by certain essential community providers. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Access to Genetic Counselor Services Act, H.R.6280. Bill would expand coverage of genetic counseling services under Medicare. Lung Cancer Screening and Prevention Act of 2025, H.R. 1406. This bill authorizes Medicare coverage of additional types of lung cancer screening tests that are approved by the FDA, regardless of whether they are recommended by the United States Preventive Services Task Force (USPSTF). Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance. Medical/Disease Research/Clinical Labs: Clinical Trial Modernization Act, H.R. 3521. Increase diversity in access to clinical trials and make it easier for all persons with cancer to participate by reducing barriers to enrollment. Barriers may include ancillary (non-medical) costs, such as transportation and lodging, and remote access to trials, particularly for people who are underrepresented, including certain racial and ethnic groups, older adults, rural residents, and those with limited incomes. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Defense: Defense Appropriations. ACS CAN advocates for cancer research funding within CDMRP. Indian/Native American Affairs: Issues relating to Indian Health Services and the Congressional Native American Caucus. FY26 appropriations for the Indian Health Service. ACS CAN advocates for full funding for FY26 and advanced FY27 appropriations to ensure American Indians and Alaska Natives have access to quality and affordable health care services. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. FY26 appropriations for the Initiative for Improving Native American Cancer Outcomes under the NIMHD and NCI. ACS CAN advocates for the continuation of full funding for the program to support research, education, outreach, and clinical access related to cancer in Native American populations.

Government entities reported: Centers For Disease Control & Prevention (CDC) Centers For Medicare and Medicaid Services (CMS) Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES Natl Institutes of Health (NIH) SENATE Food & Drug Administration (FDA)

Reported filing-period amount: $2,380,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.

Registrant: HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.

4th Quarter (Oct 1 - Dec 31)
Jan 16, 2026

Reported lobbying issue

Foreign Relations: HR 661 - MIRACLE Medical Technology Act of 2025 All provisions This bill requires the Secretary of Health and Human Services, in consultation with the Secretary of Commerce, the Council for Technology and Innovation of the Centers for Medicare & Medicaid Services, and the Commissioner of Food and Drugs, to carry out a program to facilitate and coordinate efforts between the United States and Israel to expand and enhance collaboration on the development and delivery of health care products and services. H.R. 764/S. 280 - Global Health, Empowerment and Rights Act All provisions This bill prohibits determining ineligibility of foreign nongovernmental organizations to receive assistance solely on the basis of health or medical services, including counseling and referral services, provided by such organizations with non-United States Government funds if such services do not violate the laws of the country in which they are being provided. H.R. 1229/S. 554 - United States-Israel Defense Partnership Act of 2025 All provisions This bill enhances bilateral defense cooperation between the United States and Israel. H.R. 2439 - Support UNFPA Funding Act All provisions This bill authorizes contributions to the United Nations Population Fund. H.R. 2609 - PEACE Act All provisions This bill promotes education and training to United States diplomatic personnel relating to the Abraham Accords and other normalization agreements with Israel. H.R. 3565 - To provide for a limitation on the transfer of defense articles and defense services to Israel. All provisions This bill provides for a limitation on the transfer of defense articles and defense services to Israel. H.R. 4473 - BIRD Health Act of 2025 All provisions This bill directs the Secretary of Health and Human Services to establish a bilateral research and innovation program to facilitate and coordinate efforts between the United States and Israel in certain health-related areas. H.R. 4655 - United States-Israel PTSD Collaborative Research Act All provisions This bill directs the Secretary of Defense to carry out a grant program to increase cooperation on post-traumatic stress disorder research between the United States and Israel. H.Res. 795 - Condemning the Hamas attacks of October 7, 2023, and calling for Hamas and its leaders to immediately and unconditionally surrender and to release the hostages, including Americans. All provisions. This resolution condemns the Hamas attacks of October 7, 2023, and calls for Hamas and its leaders to immediately and unconditionally surrender and to release all remaining hostages. H.Res. 839 - Condemning Hamas for assassinating innocent Palestinians. All provisions. This resolution condemns in the strongest terms the killings and acts of terror committed by Hamas against innocent Palestinians in Gaza. Health Issues: H.R. 589 - FACE Act Repeal Act of 2025 All provisions This bill amends title 18, United States Code, to repeal prohibitions relating to freedom of access to clinic entrances. H.R. 3916/S. 2029 - My Body, My Data Act of 2025 All provisions This bill creates protections for the privacy of personal reproductive or sexual health information. H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025 All provisions This bill amends title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. H.R. 1909/S. 2621 - Preventing Maternal Deaths Reauthorization Act All provisions This bill amends the Public Health Service Act to reauthorize support for State-based maternal mortality review committees, to direct the Secretary of Health and Human Services to disseminate best practices on maternal mortality prevention to hospitals, State-based professional societies, and perinatal quality collaboratives. H.R. 4849/S. 2556 - Protecting Health Care and Lowering Costs Act of 2025 All provisions This bill will repeal health-related portions of An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14, and for other purposes. H.R. 4541/S. 2339 - EARLY Act Reauthorization of 2025 All provisions. This bill reauthorizes the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009. H.R. 3037/S. 1500 - Access to Breast Cancer Diagnosis Act of 2025 All provisions. This bill amends title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. S. 1410 - Find It Early Act All provisions. This bill would ensure all health insurance plans cover screening and diagnostic breast imaging with no cost-sharing, including mammograms, ultrasounds and breast ultrasounds, and MRIs. H.R. 2048 - Metastatic Breast Cancer Access to Care Act All provisions. This bill expedites payment of Social Security Disability Insurance (SSDI) benefits and eligibility for Medicare coverage for those with metastatic breast cancer (i.e., breast cancer that has spread to other sites in the body). Education: H.R. 768/S. 332 - Holocaust Education and Antisemitism Lessons Act All provisions This bill directs the U.S. Holocaust Memorial Museum to study and report on Holocaust education efforts in states, local educational agencies (LEAs), and public elementary and secondary schools. H.R. 5714 - October 7 Remembrance Education Act All provisions. This bill directs the United States Holocaust Memorial Museum to develop a curriculum for the study of antisemitism surrounding Hamas October 7, 2023, terrorist attacks against Israel. Civil Rights/Civil Liberties: H.R. 1007/S. 558 Antisemitism Awareness Act of 2025 All provisions This bill provides for the consideration of a definition of antisemitism set forth by the International Holocaust Remembrance Alliance for the enforcement of Federal antidiscrimination laws concerning education programs or activities, and for other purposes. H.R. 15/S. 1503 - Equality Act All provisions This bill prohibits discrimination on the basis of sex, gender identity, and sexual orientation. H.R. 3691 - Commission to Study Acts of Antisemitism in the United States Act All provisions This bill establishes the Commission to Study Acts of Antisemitism in the United States to investigate the causes of antisemitism and provide policy recommendations to Congress and the President. H.R. 6857/S. 163 - Protecting Students on Campus Act of 2025 All provisions This bill requires the Department of Education (ED) and institutions of higher education (IHEs) participating in federal student aid programs to distribute information on how to report alleged violations of civil rights under Title VI of the Civil Rights Act of 1964. H.Con.Res. 65 - Commending State and local governments for championing reproductive rights as human rights. All provisions. This resolution commends State and local governments for championing reproductive rights as human rights. S.Res. 533 - A resolution condemning white supremacy, hate, and antisemitism, and efforts to give a platform to these dangerous ideologies. All provisions. This resolution condemns white supremacy, hate, and antisemitism, and efforts to give a platform to these dangerous ideologies. Medical/Disease Research/Clinical Labs: HR 2319/S 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 All provisions This bill requires a review of women and lung cancer. H.R. 2717/S. 1320 - Servicewomen and Veterans Menopause Research Act All provisions This bill directs the Secretary of Defense and the Secretary of Veterans Affairs to take certain steps regarding research related to menopause, perimenopause, or mid-life womens health. Family issues/Abortion/Adoption: H.R. 999/S. 422 - Right to Contraception Act All provisions This bill would safeguard Americans right to access all forms of birth control and protect against federal and state efforts to restrict it. H.R. 1197/S. 1562 - PREEMIE Reauthorization Act of 2025 All provisions This bill reauthorizes the Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act through FY2029 and establishes actions by the Department of Health and Human Services (HHS) to address preterm birth (i.e., babies born before 37 weeks of pregnancy). H.R. 1670/S. 797 - Family Building FEHB Fairness Act All provisions This bill adds a requirement for Federal employee health benefit plans to include assisted reproductive treatment benefits. H.R. 1878 - IVF Access and Affordability Act All provisions This bill introduces a tax credit for fertility treatments, capping at $20,000 annually, with provisions for joint filers, income-based reductions, and a five-year carryforward for unused credits, effective for taxable years post-enactment. H.R. 2049 - Access to Family Building Act All provisions This bill provides a statutory right to access assisted reproductive technology (e.g., in vitro fertilization). H.R. 2557/S. 1231 - IVF for Military Families Act All provisions This bill amends title 10, United States Code, to provide fertility treatment under the TRICARE Program. H.R. 2762/S. 1394 Expanding Access to Family Planning Act All provisions This bill provides enhanced funding for family planning services. S. 2035 Protect IVF Act All provisions This bill establishes statutory rights to choose to receive, provide, and cover fertility treatments. H.R. 12 - Womens Health Protection Act of 2025 All provisions This bill protects a persons ability to determine whether to continue or end a pregnancy, and to protect a health care providers ability to provide abortion services. H.R. 4611/S. 2377 - EACH Act of 2025 All provisions This bill aims to ensure affordable abortion coverage and care for every person. H.R. 4648/S. 2408 - Access to Fertility Treatment and Care Act All provisions This bill will require health insurance plans to provide coverage for fertility treatment. H.R. 4888/S. 2671 - Reproductive Rights are Human Rights Act of 2025 All provisions This bill will amend the Foreign Assistance Act of 1961 to require a section on reproductive rights in the Annual Country Reports on Human Rights Practices. H.R. 4977/S. 141 - Connected MOM Act All provisions This bill identifies and address barriers to coverage of remote physiologic devices under State Medicaid programs to improve maternal and child health outcomes for pregnant and postpartum women. Budget/Appropriations: H.R. 4213 - Department of Homeland Security Appropriations Act, 2026 Provisions related to increasing the authorized funding for the Nonprofit Security Grant Program This bill makes appropriations for the Department of Homeland Security for the fiscal year ending September 30, 2026. H.R. 3838/S. 2296 - Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 // National Defense Authorization Act for Fiscal Year 2026 Provisions for security and defense partnerships with Israel including US-Israel missile defense cooperation on Iron Dome and Davids Sling and Arrow defense systems; US-Israel Anti-Tunneling Cooperation; access to essential health care, including abortion, contraception, fertility, and gender-affirming medical care. This bill sets forth policies and authorities for FY2026 for Department of Defense (DOD) programs and activities, military construction, and the national security programs of the Department of Energy and the Maritime Administration. It also authorizes appropriations for the Defense Nuclear Facilities Safety Board and the Naval Petroleum Reserves, and modifies the defense acquisition system to expedite delivery of capabilities to the Armed Forces. H.R. 4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026 Provisions for increased funding and staff for the Office of the Special Envoy to Monitor and Combat Antisemitism for FY 2026. This bill provides FY2026 appropriations for national security, the Department of State, and related programs. H.R. 5304/S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 Provisions related to the Weldon Amendment, abortion coverage, access to essential health care, including abortion, contraception, fertility, and gender-affirming medical care. This bill provides for the Departments of Labor, Health and Human Services, and Education, and related programs. Intelligence: H.R. 5011 - Violent Antisemitism Threat Assessment Act All provisions This bill will require a report from the Secretary of Defense to the House and Senate Committees on Armed Services on the threat posed by violent antisemitism as a component of transnational extremist movements. Firearms/Guns/Ammunition: H.R. 38 - Constitutional Concealed Carry Reciprocity Act of 2025 All provisions. This bill establishes a federal statutory framework to regulate the carry or possession of concealed firearms across state lines.

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $60,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC

Registrant: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.

3rd Quarter (July 1 - Sep 30)
Oct 20, 2025

Reported lobbying issue

Health Issues: Access to Care One Big Beautiful Bill, H.R. 1. Advocate to protect Medicaid from cuts as part of the FY25 budget reconciliation process. Advocate for the inclusion of the enhanced premium tax credits as part of the package. Health Care Affordability Act, H.R.247, S.46. House and Senate bills would permanently extend the enhanced Affordable Care Act tax credits. Association Health Plans Act, H.R.2528. This bill would amend the Employee Retirement Income Security Act of 1974 to treat association health plans as employers. Self-Insurance Protection Act, H.R. 2571. This bill would amend the Employee Retirement Income Security Act of 1974 to exclude from the definition of health insurance coverage certain medical stop-loss insurance. Access to Breast Cancer Diagnosis Act, H.R. 3037/S.1500. To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. Women and Lung Cancer Research and Preventative Services Act of 2025, H.R.2319, S.1157. This bill requires the Department of Health and Human Services working with the Department of Defense, to conduct an interagency review to evaluate the status of and identify opportunities for research on women and lunch cancer preventative services. Education and Awareness Requires Learning (EARLY) Act, H.R. 4541, S. 2339. This bill would reauthorize the CDC program that supports young and high-risk women as well as their providers to better understand breast health. Health Disparities Nancy Gardner Sewell Medicare Early Detection Screening Coverage Act, H.R. 842, S. 339. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown. Screening for Communities to Receive Early and Equitable Needed Services (SCREENS for Cancer Act, H.R. 2381/S.1866. Reauthorizes the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2030 to provide the program greater flexibility in providing access to lifesaving screening, diagnostic, and treatment services and continue its innovative work aimed to reduce disparities and advance health equity in breast and cervical cancer. Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act, H.R. 1300, S. 297. Legislation to remove cost sharing of PSA testing for those at the highest risk of being diagnosed with prostate cancer. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Data Equity. Legislative and regulatory funding to support the collection of detailed demographic data toward reducing disparities in cancer prevention, detection, and treatment. Equality Act, H.R. 15/S. 1503. This bill prohibits discrimination based on sex, sexual orientation, or gender identity with respect to businesses, employment, housing, federally funded programs, and other settings. Henrietta Lacks Congressional Gold Medal Act, H.R. 3498/ S.1893. Legislation to award posthumously a Congressional Gold Medal to Henrietta Lacks, in recognition of her immortal cells which have made invaluable contributions to global health, scientific research, our quality of life, and patients' rights. Childhood Cancer Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 (STAR) Act. Continued implementation and funding of the Childhood Cancer STAR Act to promote the development of new, safer therapies for children with cancer. Our appropriations request includes $30 million for the Childhood Cancer STAR Act and $50 million for the Childhood Cancer Data Initiative. Accelerating Kids Access to Care Act, S.752, H.R.1509. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Give Kids and Chance Act of 2025, S.932, H.R. 1262. Legislation that would accelerate pediatric cancer treatments and expand access to live-saving therapies for children battling rare diseases, spur drug development for pediatric rare diseases, improve outcomes for patients, and close gaps in pediatric drug research. One Big Beautiful Bill, H.R. 1. Advocate to protect Medicaid for children with cancer from cuts as part of the FY25 budget reconciliation process. Quality of Life Palliative Care Palliative Care and Hospice Education and Training Act (PCHETA). Legislation to facilitate access to palliative care and coordinated care management. Palliative Care Research Funding. Funding to focus and expand national research programs in palliative care at the National Institutes of Health. Specifically, ACS CAN is working to include funding for palliative care research in the FY26 LHHS Appropriations bill. Federal Health Care Programs Women and Lung Cancer Research and Preventive Services Act of 2025, H.R.2319, S.1157 This bill requires the Department of Health and Human Services, working with the Department of Defense, to conduct an inter- agency review to evaluate the status of and identify opportunities for research on women and lung cancer preventive services. Department of Defense Cancer Research Funding. Ensure continued funding for cancer research within the DOD's Congressionally Directed Medical Research Program. Clinical Trials Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment. Barriers may include ancillary (non-medical) costs, such as transportation and lodging, and remote access to trials, particularly for people who are underrepresented, including certain racial and ethnic groups, older adults, rural residents, and those with limited incomes. To amend the Internal Revenue Act of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Taxation/Internal Revenue Code: One Big Beautiful Bill Act, H.R. 1. Advocate to protect Medicaid from cuts as part of the FY25 budget reconciliation process. Advocate for the inclusion of the enhanced premium tax credits as part of the package. Issues regarding expanding the availability of the charitable deduction for non-itemizers. Issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment. Barriers may include ancillary (non-medical) costs, such as transportation and lodging, and remote access to trials, particularly for people who are underrepresented, including certain racial and ethnic groups, older adults, rural residents, and those with limited incomes. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Health Care Affordability Act, H.R. 247, S. 46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Bipartisan Premium Tax Credit Extension Act, H.R. 5145. Bill would extend the enhanced ACA tax credits for one year. A bill to amend the Internal Revenue Code of 1986 to extend the temporary enhanced premium credits, S.2824. Bill would extend the enhanced ACA tax credits for two years. Tobacco: Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments.; Issues relating to FDA regulation of flavors, electronic cigarettes and cigars Budget/Appropriations: One Big Beautiful Bill Act, H.R. 1. Advocate to protect Medicaid from cuts as part of the FY25 budget reconciliation process. Advocate for inclusion of the enhanced premium tax credits as part of the package. ACS CAN advocated for full implementation of the law and for funding to be issued consistent with statute. FY26 House and Senate Labor, Health and Human Services legislation. ACS CAN advocates for increases in cancer research and prevention, including NIH, NCI, CDC DCPC, and OSH funding. FY25 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP and funding for the Initiative for Improving Native American Cancer Outcomes through NCIs coordination with NIMHD. FY26 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP. ACS CAN advocates for increases in programs that advance research for cancers include the Peer Reviewed Cancer Research Program (PRCRP). FY26 Interior Appropriations for Indian Health Services funding. ACS CAN advocates for increased funding for health with a focus on cancer funding. FY26 Agriculture and FDA Appropriations for issues related to drug shortages and tobacco. ACS CAN advocates for funding for the FDA, for provisions to address drug shortages, and on tobacco policy including issues related to the FDA regulation of flavors, electronic cigarettes, and cigars. Medicare/Medicaid: One Big Beautiful Bill Act, H.R. 1. Advocate to protect Medicaid from cuts as part of the FY25 budget reconciliation process. Advocate for inclusion of the enhanced premium tax credits as part of the package. Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act, H.R. 842, S.339. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown. Lung Cancer Screening and Prevention Act, H.R. 140. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Accelerating Kids Access to Care Act, S.752, H.R. 150. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Ensuring Access to Essential Providers Act, S.2793. Bill would require Medicare Advantage plans to cover items and services furnished by certain essential community providers. Medical/Disease Research/Clinical Labs: Clinical Trial Modernization Act, H.R. 3521. Increase diversity in access to clinical trials and make it easier for all persons with cancer to participate by reducing barriers to enrollment. Barriers may include ancillary (non-medical) costs, such as transportation and lodging, and remote access to trials, particularly for people who are underrepresented, including certain racial and ethnic groups, older adults, rural residents, and those with limited incomes. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Defense: Defense Appropriations. ACS CAN advocates for cancer research funding within CDMRP. Indian/Native American Affairs: Issues relating to Indian Health Services and the Congressional Native American Caucus. FY26 appropriations for the Indian Health Service. ACS CAN advocates for full funding for FY26 and advanced FY27 appropriations to ensure American Indians and Alaska Natives have access to quality and affordable health care services. FY26 appropriations for the Initiative for Improving Native American Cancer Outcomes under the NIMHD and NCI. ACS CAN advocates for the continuation of full funding for the program to support research, education, outreach, and clinical access related to cancer in Native American populations.

Government entities reported: Centers For Disease Control & Prevention (CDC) Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES Natl Institutes of Health (NIH) SENATE Food & Drug Administration (FDA)

Reported filing-period amount: $2,130,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

GE HEALTHCARE TECHNOLOGIES INC.

Registrant: GE HEALTHCARE TECHNOLOGIES INC.

3rd Quarter (July 1 - Sep 30)
Oct 20, 2025

Reported lobbying issue

Health Issues: Issues impacting artificial intelligence. Issues impacting corporate taxation. Issues impacting funding for health care including government research. Issues impacting health care and public health. Issues impacting manufacturing. Issues impacting medical device and health care cybersecurity. Issues impacting medical device regulation. Issues impacting medical insurance coverage. Issues impacting medical research. Issues impacting Medicare coverage and reimbursement for medical technology and health care services. Issues impacting radiopharmacetucials. Issues impacting servicing and repair of medical devices. Issues impacting wireless spectrum. Issues impacting international trade and supply chains. Issues impacting Veterans health. Issues related to insurance coverage for breast cancer screening. Issues related to maternal health. Issues related to critical minerals. PL 119-21, implementation of provisions related to the taxation of corporations. S. 1399, Health Tech Investment Act, all provisions. S. 1410, Find It Early Act, all provisions. S. 1500/H.R. 3037 Access to Breast Cancer Diagnosis Act, all provisions. S. 2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act 2026, provisions related to healthcare. H.R. 5304, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act 2026, provisions related to healthcare. H.R. 4121, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2026, provisions related to healthcare. S. 2256, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2026, provisions related to healthcare. S. 2296, National Defense Authorization Act for Fiscal Year 2026, provisions related to healthcare. H.R. 3838, Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026, provisions related to healthcare.

Government entities reported: Commerce, Dept of (DOC) Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES Office of Management & Budget (OMB) SENATE Treasury, Dept of U.S. Trade Representative (USTR)

Reported filing-period amount: $370,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC

Registrant: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.

2nd Quarter (Apr 1 - June 30)
Jul 21, 2025

Reported lobbying issue

Health Issues: Access to Care One Big Beautiful Bill, H.R. 1. Advocate to protect Medicaid from cuts as part of the FY25 budget reconciliation process. Advocate for the inclusion of the enhanced premium tax credits as part of the package. Health Care Affordability Act, H.R.247, S.46. House and Senate bills would permanently extend the enhanced Affordable Care Act tax credits. Association Health Plans Act, H.R.2528. This bill would amend the Employee Retirement Income Security Act of 1974 to treat association health plans as employers. Self-Insurance Protection Act, H.R. 2571. This bill would amend the Employee Retirement Income Security Act of 1974 to exclude from the definition of health insurance coverage certain medical stop-loss insurance. Access to Breast Cancer Diagnosis Act, H.R. 3037/S.1500. To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. Women and Lung Cancer Research and Preventative Services Act of 2025, H.R.2319, S.1157. This bill requires the Department of Health and Human Services working with the Department of Defense, to conduct an interagency review to evaluate the status of and identify opportunities for research on women and lunch cancer preventative services. Health Disparities Nancy Gardner Sewell Medicare Early Detection Screening Coverage Act, H.R. 842, S. 339. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown. Screening for Communities to Receive Early and Equitable Needed Services (SCREENS for Cancer Act, H.R. 2381/S.1866. Reauthorizes the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2030 to provide the program greater flexibility in providing access to lifesaving screening, diagnostic, and treatment services and continue its innovative work aimed to reduce disparities and advance health equity in breast and cervical cancer. Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act, H.R. 1300, S. 297. Legislation to remove cost sharing of PSA testing for those at the highest risk of being diagnosed with prostate cancer. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Data Equity. Legislative and regulatory funding to support the collection of detailed demographic data toward reducing disparities in cancer prevention, detection, and treatment. Equality Act, H.R. 15/S. 1503. This bill prohibits discrimination based on sex, sexual orientation, or gender identity with respect to businesses, employment, housing, federally funded programs, and other settings. Henrietta Lacks Congressional Gold Medal Act, H.R. 3498/ S.1893. Legislation to award posthumously a Congressional Gold Medal to Henrietta Lacks, in recognition of her immortal cells which have made invaluable contributions to global health, scientific research, our quality of life, and patients' rights. Childhood Cancer Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 (STAR) Act. Continued implementation and funding of the Childhood Cancer STAR Act to promote the development of new, safer therapies for children with cancer. Our appropriations request includes $30 million for the Childhood Cancer STAR Act and $50 million for the Childhood Cancer Data Initiative. Accelerating Kids Access to Care Act, S.752, H.R.1509. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Give Kids and Chance Act of 2025, S.932, H.R. 1262. Legislation that would accelerate pediatric cancer treatments and expand access to live-saving therapies for children battling rare diseases, spur drug development for pediatric rare diseases, improve outcomes for patients, and close gaps in pediatric drug research. One Big Beautiful Bill, H.R. 1. Advocate to protect Medicaid for children with cancer from cuts as part of the FY25 budget reconciliation process. Quality of Life Palliative Care Palliative Care and Hospice Education and Training Act (PCHETA). Legislation to facilitate access to palliative care and coordinated care management. Palliative Care Research Funding. Funding to focus and expand national research programs in palliative care at the National Institutes of Health. Specifically, ACS CAN is working to include funding for palliative care research in the FY26 LHHS Appropriations bill. Federal Health Care Programs Increased Funding Levels for Cancer Research and Prevention. Ensure continued progress in the fight against cancer at the National Institutes of Health (NIH), the National Cancer Institute (NCI), the Advanced Research Projects Agency for Health (ARPA-H), and the Centers for Disease Control and Preventions (CDC), Division of Cancer Prevention and Control (DCPC). Women and Lung Cancer Research and Preventive Services Act of 2025, H.R.2319, S.1157 This bill requires the Department of Health and Human Services, working with the Department of Defense, to conduct an inter- agency review to evaluate the status of and identify opportunities for research on women and lung cancer preventive services. Department of Defense Cancer Research Funding. Ensure continued funding for cancer research within the DOD's Congressionally Directed Medical Research Program. Clinical Trials Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment. Barriers may include ancillary (non-medical) costs, such as transportation and lodging, and remote access to trials, particularly for people who are underrepresented, including certain racial and ethnic groups, older adults, rural residents, and those with limited incomes. To amend the Internal Revenue Act of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Taxation/Internal Revenue Code: One Big Beautiful Bill Act, H.R. 1. Advocate to protect Medicaid from cuts as part of the FY25 budget reconciliation process. Advocate for the inclusion of the enhanced premium tax credits as part of the package. Issues regarding expanding the availability of the charitable deduction for non-itemizers. Issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment. Barriers may include ancillary (non-medical) costs, such as transportation and lodging, and remote access to trials, particularly for people who are underrepresented, including certain racial and ethnic groups, older adults, rural residents, and those with limited incomes. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Health Care Affordability Act, H.R. 247, S. 46. House and Senate bills would permanently extend the enhanced Affordable Care Act tax credits. Tobacco: Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments.; Issues relating to FDA regulation of flavors, electronic cigarettes and cigars Budget/Appropriations: One Big Beautiful Bill Act, H.R. 1. Advocate to protect Medicaid from cuts as part of the FY25 budget reconciliation process. Advocate for inclusion of the enhanced premium tax credits as part of the package. FY25 and FY26 House Labor, Health and Human Services legislation. ACS CAN advocates for increases in cancer research and prevention, including NIH, NCI, CDC DCPC, and OSH funding. FY25 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP and funding for the Initiative for Improving Native American Cancer Outcomes through NCIs coordination with NIMHD. FY25 and FY26 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP. FY25 VA Appropriations for PACT Act Funding. ACS CAN advocates for full funding for the PACT Act. FY25 AND FY26 Interior Appropriations for Indian Health Services funding. ACS CAN advocates for increased funding for health with a focus on cancer funding. FY25 and FY26 Agriculture and FDA Appropriations for issues related to drug shortages and tobacco. ACS CAN advocates for funding for the FDA, for provisions to address drug shortages, and on tobacco policy including issues related to the FDA regulation of flavors, electronic cigarettes, and cigars. Medicare/Medicaid: One Big Beautiful Bill Act, H.R. 1. Advocate to protect Medicaid from cuts as part of the FY25 budget reconciliation process. Advocate for inclusion of the enhanced premium tax credits as part of the package. Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act, H.R. 842, S.339. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown. Lung Cancer Screening and Prevention Act, H.R. 140. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Accelerating Kids Access to Care Act, S.752, H.R. 150. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Medical/Disease Research/Clinical Labs: Clinical Trial Modernization Act, H.R. 3521. Increase diversity in access to clinical trials and make it easier for all persons with cancer to participate by reducing barriers to enrollment. Barriers may include ancillary (non-medical) costs, such as transportation and lodging, and remote access to trials, particularly for people who are underrepresented, including certain racial and ethnic groups, older adults, rural residents, and those with limited incomes. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Defense: Defense Appropriations. ACS CAN advocates for cancer research funding within CDMRP. Indian/Native American Affairs: Issues relating to Indian Health Services and the Congressional Native American Caucus

Government entities reported: Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES Indian Health Service Natl Institutes of Health (NIH) SENATE

Reported filing-period amount: $2,630,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

GE HEALTHCARE TECHNOLOGIES INC.

Registrant: GE HEALTHCARE TECHNOLOGIES INC.

2nd Quarter (Apr 1 - June 30)
Jul 21, 2025

Reported lobbying issue

Health Issues: Issues impacting artificial intelligence. Issues impacting corporate taxation. Issues impacting funding for health care including government research. Issues impacting health care and public health. Issues impacting manufacturing. Issues impacting medical device and health care cybersecurity. Issues impacting medical device regulation. Issues impacting medical insurance coverage. Issues impacting medical research. Issues impacting Medicare coverage and reimbursement for medical technology and health care services. Issues impacting radiopharmaceuticals. Issues impacting servicing and repair of medical devices. Issues impacting wireless spectrum. Issues impacting international trade and supply chains. Issues impacting Veterans health. Issues related to insurance coverage for breast cancer screening. Issues related to maternal health. Issues related to critical minerals. S. 1399, Health Tech Investment Act, all provisions. H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14, provisions related to the taxation of corporations. S. 1410, Find It Early Act, all provisions. S. 1500/H.R. 3037 Access to Breast Cancer Diagnosis Act, all provisions.

Government entities reported: Commerce, Dept of (DOC) Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES SENATE Treasury, Dept of U.S. Trade Representative (USTR)

Reported filing-period amount: $350,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN

Registrant: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN

2nd Quarter (Apr 1 - June 30)
Jul 21, 2026

Reported lobbying issue

Budget/Appropriations: H.R.8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; a bill making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2027, and for other purposes H.R.9495 - Department of Defense Appropriations Act, 2027; a bill making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; a bill making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. FY27 appropriations related to funding for biomedical research, National Breast and Cervical Cancer Early Detection Program, cancer prevention and control, FDA funding, and related cancer services Insurance: H.R.3037/S.1500 - Access to Breast Cancer Diagnosis Act; a bill to eliminate cost sharing for medically necessary diagnostic and supplemental breast imaging for patients with private insurance Medicare/Medicaid: H.R.2048/S.3442 - Metastatic Breast Cancer Access to Care Act; a bill to amend title II of the Social Security Act to eliminate the waiting periods for disability insurance benefits and Medicare coverage for individuals with metastatic breast cancer, and for other purposes H.R.6280/S.3607- Access to Genetic Counselor Services Act of 2026; a bill to amend title XVIII of the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under part B of the Medicare program, and for other purposes. H.R.4752/S.27060 - Reducing Hereditary Cancer Act; a bill to amend title XVIII of the Social Security Act to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer. Comments in response to Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Children's Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, and Issuers of Qualified Health Plans on the Federally-Facilitated Exchanges (CMS-0062-P) Activities related to the implementation of H.R. 1 the One Big Beautiful Bill Act Health Issues: H.R.2381/S.1866 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to reauthorize the National Breast and Cervical Cancer Early Detection Program H.R.4541/S.2339 - The EARLY Act Reauthorization of 2025; a bill to reauthorize the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009. H.R.8358/S.4318 - Breast Cancer Research Stamp Reauthorization Act; efforts to introduce a bill to amend title 39, United States Code, to extend the authority of the United States Postal Service to issue a semipostal to raise funds for breast cancer research. H.R.8839 - Lainie Jones Comprehensive Cancer Survivorship Act of 2026; a bill to address the health of cancer survivors and unmet needs that survivors face through the entire continuum of care from diagnosis through active treatment and posttreatment, in order to improve survivorship, treatment, transition to recovery and beyond, quality of life and palliative care, and long-term health outcomes, including by developing a minimum standard of care for cancer survivorship, irrespective of the type of cancer, a survivors background, or forthcoming survivorship needs, and for other purposes. H.R.3521/S.4440 - Clinical Trial Modernization Act; a bill to modernize clinical trials and remove barriers for participation in clinical trials, and for other purposes. H.Res.1196 - Recognizing April as Cancer Prevention and Early Detection Month; a House resolution to recognize April as Cancer Prevention and Early Detection month Efforts to introduce legislation related to the establishment of an interagency task force on breast cancer risk assessment tools Efforts related to the Office of Management and Budget Proposed Rule to revise the Guidance for Federal Financial Assistance Comments related the CMS Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model and Medicares six protected classes Postal: H.R.8358/S.4318 - Breast Cancer Research Stamp Reauthorization Act; efforts to introduce a bill to amend title 39, United States Code, to extend the authority of the United States Postal Service to issue a semipostal to raise funds for breast cancer research.

Government entities reported: HOUSE OF REPRESENTATIVES SENATE Centers For Medicare and Medicaid Services (CMS) Health & Human Services, Dept of (HHS) Office of Management & Budget (OMB)

Reported filing-period amount: $130,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

NOVARTIS

Registrant: NOVARTIS

2nd Quarter (Apr 1 - June 30)
Jul 20, 2026

Reported lobbying issue

Budget/Appropriations: H.R. 5371: Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 Funding for FDA - FY 2026 Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2026 FY 2026 President's Budget Request Inflation Reduction Act of 2022 (P.L. 117-169) Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 Federal Budget Funding for National Institutes of Health - FY 2026 Appropriations H.R. 1: One Big Beautiful Bill Act (P.L. 119-21) FY 2027 President's Budget H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Copyright/Patent/Trademark: S. 43: Skinny Labels, Big Savings Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 2276/HR. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues Patent eligibility policy issues S. 1546/H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) Restrictions on Intellectual Property Rights PTAB reform Patent fee policy issues Section 101 reform Health Issues: Direct to Consumer Advertising 340B Drug Discount Program - Program Implementation & Oversight 340B PATIENTS Act of 2024 340B Drug Discount Program - RFI for SUSTAIN 340B Act HR. 5256 - 340B Affording Care for Communities and Ensuring a Strong Safety-Net Act(340B ACCESS Act) To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program 340B drug discount program rebate and policy issues 340B rebate pilot program H.R.9504: Tax Exempt Hospital Transparency Act 340B Program Implementation & Oversight H.R. 9599 - SECURE 340B Act Accelerated Approval Breast Cancer Research H.R.3037, Access to Breast Cancer Diagnostic Act of 2025 S.1500, Access to Breast Cancer Diagnostic Act of 2025 Alternative Funding Programs Supply Chain Integrity and Traceability PBM Reform Modernizing and Ensuring PBM Accountability (MEPA) Act Coverage of Accelerated Approval Products Drug Benefit Design Orphan Drug Issues S. 1682/H.R.946: ORPHAN Cures Act S.932/H.R. 1262: Give Kids a Chance Act of 2025 Innovation in Pediatric Drugs Act S.864: HELP Copays Act Reimbursement and Coverage of Innovative Products Lower Costs, More Transparency Act Lower Costs, More Cures Act Medicare Part B Physician-Administered Products Patient Cost-Sharing and Smoothing Step Therapy Support of Patient Premiums and Cost-Sharing Obligations Value-based Contracting and Communications H.R. 2214: DRUG Act User fee policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Drug importation policy issues FDA regulatory approval authority policy issues Competition policy issues Clinical trial diversity policy issues Patient assistance program policy issues Drug shortages policy issues Artificial intelligence policy issues IRA price negotiation expansion policy issues Rare Pediatric Disease Priority Review Voucher program policies SUSTAIN RFI/discussion draft Most Favored Nation (MFN) policy Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First Utilization management policies Clinical trial data in China S.3788: CLEAR Labels Act S. 4784/H.R. 8800: National Defense Authorization Act for Fiscal Year 2027 Medicare/Medicaid: GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule H.R. 950: Saving Seniors Money on Prescriptions Act Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues S. 832/H.R. 1492: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 H.R.1672: Maintaining Investments in New Innovation Act or the MINI Act of 2025 Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues H.R. 5391/S. 2764 Protecting Patient Access to Cancer and Complex Therapies Act Drug cost and pricing policy issues Medicare rebate policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues Taxation/Internal Revenue Code: Domestic and International Tax Policy Issues Research & Development Tax Credit Reforms Foreign Direct Investment Expensing of R&D Expenditures H.R. 2425 - Unfair Tax Prevention Act of 2025 Tax Cuts and Jobs Act, PL 115-97 H.R. 1: One Big Beautiful Bill Act (P.L. 119-21) Trade (domestic/foreign): Sec. 301 pharmaceutical tariffs US-UK Framework Agreement Tariff policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues International pharmaceutical pricing and reimbursement policy issues Supply chain policy issues China outbound investment policy issues US Swiss Trade Agreement US Trade Policy Sec. 232 pharmaceutical tariffs Pharmaceutical manufacturing policy and investment issues Outbound Investment Security Program H.R. 9102 - Biotech Investment National Security Act Labor Issues/Antitrust/Workplace: Anti-Trust Reform

Government entities reported: Centers For Medicare and Medicaid Services (CMS) Executive Office of the President (EOP) Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES Office of Management & Budget (OMB) SENATE White House Office Commerce, Dept of (DOC) Patent & Trademark Office (PTO) U.S. Trade Representative (USTR) Congressional Budget Office (CBO) Food & Drug Administration (FDA) Health Resources & Services Administration (HRSA) Treasury, Dept of

Reported filing-period amount: $1,410,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

SUSAN G. KOMEN

Registrant: ARTEMIS POLICY GROUP LLC

2nd Quarter (Apr 1 - June 30)
Jul 20, 2026

Reported lobbying issue

Budget/Appropriations: FY27 appropriations for the National Breast and Cervical Cancer Early Detection Program FY27 appropriations for breast cancer research FY27 appropriations for cancer prevention and control Insurance: Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Protect patients from substandard and junk insurance products Implementation of One Big Beautiful Bill Act (H.R.1) Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions Medicare/Medicaid: Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act H.R.8839 - Lainie Jones Comprehensive Cancer Survivorship Act of 2026 Policies related to the operations of pharmacy benefits managers: comments on proposed rules re PBM transparency (EBSA-2026-0001) and prior authorization for prescription drugs (CMS-0062-P) Implementation of Medicaid Community Engagement requirements Health Issues: Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies related to the availability and patient awareness of breast cancer risk assessments H.R. 4541, the EARLY Act Reauthorization of 2025 Issues related to the US Preventive Services Task Force

Government entities reported: Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES SENATE Centers For Medicare and Medicaid Services (CMS)

Reported filing-period amount: $40,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN

Registrant: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN

1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026

Reported lobbying issue

Postal: H.R.8358/S.4318 - Breast Cancer Research Stamp Reauthorization Act; efforts to introduce a bill to amend title 39, United States Code, to extend the authority of the United States Postal Service to issue a semipostal to raise funds for breast cancer research. Budget/Appropriations: H.R.5304/S.2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; a bill to provide for FY2026 appropriations to the Departments of Labor, Health and Human Services, and Education; and related agencies. H.R.4016/S.2572 - Department of Defense Appropriations Act, 2026; a bill to provide for FY2026 appropriations to the Department of Defense (DOD) for military activities. H.R.7148 - Consolidated Appropriations Act, 2026; a bill to provide appropriations to several federal departments and agencies, including the Departments of Defense and Labor, Health and Human Services, and Education, for the remainder of FY2026 and provides continuing FY2026 appropriations for the Department of Homeland Security (DHS) through February 13, 2026. FY26 appropriations related to funding for biomedical research, National Breast and Cervical Cancer Early Detection Program, cancer prevention and control, FDA funding workforce and related cancer services FY27 appropriations related to funding for biomedical research, National Breast and Cervical Cancer Early Detection Program, cancer prevention and control, FDA funding workforce and related cancer services and report language related to the implementation of the Medicare Prescription Payment Plan Insurance: H.R.3037/S.1500 - Access to Breast Cancer Diagnosis Act; a bill to eliminate cost sharing for medically necessary diagnostic and supplemental breast imaging for patients with private insurance H.R.5813 - Womens Health and Cancer Rights Modernization Act of 2025; a bill to amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to require group health plans and health insurance issuers offering group or individual health insurance coverage to provide coverage of certain items and services relating to breast or chest wall reconstruction furnished in connection with breast cancer treatment. Comments related to a Ways and Means Full Committee Hearing with Health Insurance CEOs Comments related to an Energy and Commerce Health Subcommittee Hearing on Lowering Health Care Costs for All Americans: An Examination of Health Insurance Affordability Implementation of the Affordable Care Act and policies related to the extension of Advanced Enhanced Premium Tax Credits Comments related to a Ways and Means Committee Hearing: Lowering Health Care Costs for All Americans Comments and engagement related to the implementation of the Affordable Care Act and H.R.1, the Big Beautiful Bill Act and relevant changes to the ACA Marketplace Comments related to Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P) Medicare/Medicaid: H.R.842/S.339 - Medicare Multi-Cancer Early Detection Screening Coverage Act; a bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests H.R.2048/S.3442 - Metastatic Breast Cancer Access to Care Act; a bill to amend title II of the Social Security Act to eliminate the waiting periods for disability insurance benefits and Medicare coverage for individuals with metastatic breast cancer, and for other purposes Comments related to Medicare Program; Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program (CMS-4212-P) Comments related to CMS Proposed Rule on Global Benchmark for Efficient Drug Pricing (GLOBE) Model (CMS-5545-P) Comments related to CMS Proposed Rule on Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model (CMS-5546-P) Comments related to CMS public engagement on the Implementation of Sections 1191 - 1198 of the Social Security Act for Initial Price Applicability Year 2028 and Manufacturer Effectuation of the Maximum Fair Price in 2026, 2027, and 2028 Health Issues: H.R.2381/S.1866 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to reauthorize the National Breast and Cervical Cancer Early Detection Program H.R.4541/S.2339 - The EARLY Act Reauthorization of 2025; a bill To reauthorize the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009. H.R.8358/S.4318 - Breast Cancer Research Stamp Reauthorization Act; efforts to introduce a bill to amend title 39, United States Code, to extend the authority of the United States Postal Service to issue a semipostal to raise funds for breast cancer research. Comments related to Solicitation of Proposals for New and Modified Safe Harbors and Special Fraud Alerts OIG-1125-N Comments in response to HHS Request for Information: Accelerating the Adoption and Use of Artificial Intelligence as Part of Clinical Care (RIN 0955-AA13)

Government entities reported: HOUSE OF REPRESENTATIVES SENATE Health & Human Services, Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)

Reported filing-period amount: $80,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

NOVARTIS

Registrant: NOVARTIS

1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026

Reported lobbying issue

Labor Issues/Antitrust/Workplace: Anti-Trust Reform Budget/Appropriations: H.R. 5371: Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 Funding for FDA - FY 2026 Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2026 FY 2026 President's Budget Request Inflation Reduction Act of 2022 (P.L. 117-169) Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 Federal Budget Funding for National Institutes of Health - FY 2026 Appropriations H.R. 1: One Big Beautiful Bill Act (P.L. 119-21) FY 2027 President's Budget H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Copyright/Patent/Trademark: S. 43: Skinny Labels, Big Savings Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 2276/HR. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues Patent eligibility policy issues H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) Restrictions on Intellectual Property Rights PTAB reform Patent fee policy issues Health Issues: Direct to Consumer Advertising 340B Drug Discount Program - Program Implementation & Oversight 340B PATIENTS Act of 2024 340B Drug Discount Program - RFI for SUSTAIN 340B Act HR. 5256 - 340B Affording Care for Communities and Ensuring a Strong Safety-Net Act(340B ACCESS Act) To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program 340B drug discount program rebate and policy issues 340B rebate pilot program Accelerated Approval Breast Cancer Research H.R.3037, Access to Breast Cancer Diagnostic Act of 2025 S.1500, Access to Breast Cancer Diagnostic Act of 2025 Alternative Funding Programs Supply Chain Integrity and Traceability PBM Reform Modernizing and Ensuring PBM Accountability (MEPA) Act Coverage of Accelerated Approval Products Drug Benefit Design Orphan Drug Issues S. 1682/H.R.946: ORPHAN Cures Act S.932/H.R. 1262: Give Kids a Chance Act of 2025 Innovation in Pediatric Drugs Act S.864: HELP Copays Act Reimbursement and Coverage of Innovative Products Lower Costs, More Transparency Act Lower Costs, More Cures Act Medicare Part B Physician-Administered Products Patient Cost-Sharing and Smoothing Step Therapy Support of Patient Premiums and Cost-Sharing Obligations Value-based Contracting and Communications H.R. 2214: DRUG Act User fee policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Drug importation policy issues FDA regulatory approval authority policy issues Competition policy issues Clinical trial diversity policy issues Patient assistance program policy issues Drug shortages policy issues Artificial intelligence policy issues IRA price negotiation expansion policy issues Rare Pediatric Disease Priority Review Voucher program policies SUSTAIN RFI/discussion draft Most Favored Nation (MFN) policy Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First Utilization management policies Medicare/Medicaid: GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule H.R. 950: Saving Seniors Money on Prescriptions Act Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues S. 832/H.R. 1492: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 H.R.1672: Maintaining Investments in New Innovation Act or the MINI Act of 2025 Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues H.R. 5391/S. 2764 Protecting Patient Access to Cancer and Complex Therapies Act Taxation/Internal Revenue Code: Domestic and International Tax Policy Issues Research & Development Tax Credit Reforms Foreign Direct Investment Expensing of R&D Expenditures H.R. 2425 - Unfair Tax Prevention Act of 2025 Tax Cuts and Jobs Act, PL 115-97 H.R. 1: One Big Beautiful Bill Act (P.L. 119-21) Trade (domestic/foreign): Sec. 301 pharmaceutical tariffs US-UK Framework Agreement Tariff policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues International pharmaceutical pricing and reimbursement policy issues Supply chain policy issues China outbound investment policy issues US Swiss Trade Agreement US Trade Policy Sec. 232 pharmaceutical tariffs Pharmaceutical manufacturing policy and investment issues

Government entities reported: HOUSE OF REPRESENTATIVES SENATE Centers For Medicare and Medicaid Services (CMS) Executive Office of the President (EOP) Health & Human Services, Dept of (HHS) Office of Management & Budget (OMB) White House Office Commerce, Dept of (DOC) Patent & Trademark Office (PTO) U.S. Trade Representative (USTR) Congressional Budget Office (CBO) Food & Drug Administration (FDA) Treasury, Dept of

Reported filing-period amount: $3,930,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

SUSAN G. KOMEN

Registrant: ARTEMIS POLICY GROUP LLC

1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026

Reported lobbying issue

Budget/Appropriations: FY26 and FY27 appropriations for the National Breast and Cervical Cancer Early Detection Program FY26 and FY27 appropriations for breast cancer research FY26 and FY27 appropriations for cancer prevention and control Insurance: Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products Implementation of One Big Beautiful Bill Act (H.R.1) Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions Comments on Proposed Rule: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P) Medicare/Medicaid: Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act Submission of Information about Selected Drugs and Their Therapeutic Alternatives for Medicare Drug Price Negotiation Comments on CMS-5546-P: Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model Comments on RE: CMS-5545-P: Global Benchmark for Efficient Drug Pricing (GLOBE) Model Health Issues: Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies related to the availability and patient awareness of breast cancer risk assessments H.R. 4541, the EARLY Act Reauthorization of 2025 Comments RE: HHS Health Sector AI RFI Comments RE: Solicitation of Proposals for New and Modified Safe Harbors and Special Fraud Alerts OIG-1125-N, (Annual Solicitation)

Government entities reported: Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES SENATE Centers For Medicare and Medicaid Services (CMS)

Reported filing-period amount: $40,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

NOVARTIS

Registrant: NOVARTIS

2nd Quarter (Apr 1 - June 30)
Mar 9, 2026

Reported lobbying issue

Budget/Appropriations: Funding for FDA - FY 2026 Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2026 FY 2026 President's Budget Request Inflation Reduction Act of 2022 (P.L. 117-169) Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 Federal Budget Funding for National Institutes of Health - FY 2026 Appropriations H.R. 1: One Big Beautiful Bill Act (P.L. 119-21) Copyright/Patent/Trademark: S. 43: Skinny Labels, Big Savings Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues Patent eligibility policy issues H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) Health Issues: 340B Drug Discount Program - Program Implementation & Oversight 340B PATIENTS Act of 2024 340B Drug Discount Program - RFI for SUSTAIN 340B Act 340B Affording Care for Communities and Ensuring a Strong Safety-Net Act(340B ACCESS Act) To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program Accelerated Approval Breast Cancer Research Breast Cancer Diagnostics H.R.3037, Access to Breast Cancer Diagnostic Act of 2025 S.1500, Access to Breast Cancer Diagnostic Act of 2025 Alternative Funding Programs Supply Chain Integrity and Traceability PBM Reform Modernizing and Ensuring PBM Accountability (MEPA) Act Coverage of Accelerated Approval Products Drug Benefit Design Orphan Drug Issues H.R.946: ORPHAN Cures Act H.R. 1262: Give Kids a Chance Act of 2025 Innovation in Pediatric Drugs Act S.864: HELP Copays Act Reimbursement and Coverage of Innovative Products Lower Costs, More Transparency Act Lower Costs, More Cures Act Medicare Part B Physician-Administered Products Patient Cost-Sharing and Smoothing Step Therapy Support of Patient Premiums and Cost-Sharing Obligations Value-based Contracting and Communications H.R. 2214: DRUG Act User fee policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Drug importation policy issues FDA regulatory approval authority policy issues Competition policy issues Clinical trial diversity policy issues Drug shortages policy issues Artificial intelligence policy issues IRA price negotiation expansion policy issues Rare Pediatric Disease Priority Review Voucher program policies SUSTAIN RFI/discussion draft Most Favored Nation policy Medicare/Medicaid: H.R. 950: Saving Seniors Money on Prescriptions Act Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues S. 832/H.R. 1492: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 H.R.1672: Maintaining Investments in New Innovation Act or the MINI Act of 2025 Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues Taxation/Internal Revenue Code: Domestic and International Tax Policy Issues Research & Development Tax Credit Reforms Tax Relief for American Families and Workers Act Foreign Direct Investment Expensing of R&D Expenditures H.R. 2425 - Unfair Tax Prevention Act of 2025 Tax Cuts and Jobs Act, PL 115-97 H.R. 1: One Big Beautiful Bill Act (P.L. 119-21) Trade (domestic/foreign): Tariff policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues China outbound investment policy issues US Swiss Trade Agreement US Trade Policy Labor Issues/Antitrust/Workplace: Anti-Trust Reform

Government entities reported: Centers For Medicare and Medicaid Services (CMS) Executive Office of the President (EOP) Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES SENATE White House Office Commerce, Dept of (DOC) Patent & Trademark Office (PTO) U.S. Trade Representative (USTR) Congressional Budget Office (CBO) Food & Drug Administration (FDA) Office of Management & Budget (OMB)

Reported filing-period amount: $920,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

NOVARTIS

Registrant: NOVARTIS

3rd Quarter (July 1 - Sep 30)
Mar 9, 2026

Reported lobbying issue

Budget/Appropriations: Funding for FDA - FY 2026 Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2026 FY 2026 President's Budget Request Inflation Reduction Act of 2022 (P.L. 117-169) Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 Federal Budget Funding for National Institutes of Health - FY 2026 Appropriations H.R. 1: One Big Beautiful Bill Act (P.L. 119-21) Copyright/Patent/Trademark: S. 43: Skinny Labels, Big Savings Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 2276/HR. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues Patent eligibility policy issues H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) Health Issues: 340B Drug Discount Program - Program Implementation & Oversight 340B PATIENTS Act of 2024 340B Drug Discount Program - RFI for SUSTAIN 340B Act HR. 5256 - 340B Affording Care for Communities and Ensuring a Strong Safety-Net Act(340B ACCESS Act) To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program 340B drug discount program rebate and policy issues 340B rebate pilot program Accelerated Approval Breast Cancer Research Breast Cancer Diagnostics H.R.3037, Access to Breast Cancer Diagnostic Act of 2025 S.1500, Access to Breast Cancer Diagnostic Act of 2025 Alternative Funding Programs Supply Chain Integrity and Traceability PBM Reform Modernizing and Ensuring PBM Accountability (MEPA) Act Coverage of Accelerated Approval Products Drug Benefit Design Orphan Drug Issues H.R.946: ORPHAN Cures Act S.932/H.R. 1262: Give Kids a Chance Act of 2025 Innovation in Pediatric Drugs Act S.864: HELP Copays Act Reimbursement and Coverage of Innovative Products Lower Costs, More Transparency Act Lower Costs, More Cures Act Medicare Part B Physician-Administered Products Patient Cost-Sharing and Smoothing Step Therapy Support of Patient Premiums and Cost-Sharing Obligations Value-based Contracting and Communications H.R. 2214: DRUG Act User fee policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Drug importation policy issues FDA regulatory approval authority policy issues Competition policy issues Clinical trial diversity policy issues Patient assistance program policy issues Drug shortages policy issues Artificial intelligence policy issues IRA price negotiation expansion policy issues Rare Pediatric Disease Priority Review Voucher program policies SUSTAIN RFI/discussion draft Most Favored Nation (MFN) policy MAHA Commission Report - Make Our Children Healthy Again Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First Presidential Memoranda: Memorandum for the Secretary of Health and Human Services the Commissioner of Drugs - Addressing Misleading Direct-to-Consumer Prescription Drug Advertisements Medicare/Medicaid: H.R. 950: Saving Seniors Money on Prescriptions Act Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues S. 832/H.R. 1492: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 H.R.1672: Maintaining Investments in New Innovation Act or the MINI Act of 2025 Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues Taxation/Internal Revenue Code: Domestic and International Tax Policy Issues Research & Development Tax Credit Reforms Foreign Direct Investment Expensing of R&D Expenditures H.R. 2425 - Unfair Tax Prevention Act of 2025 Tax Cuts and Jobs Act, PL 115-97 H.R. 1: One Big Beautiful Bill Act (P.L. 119-21) Trade (domestic/foreign): Tariff policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues International Pharmaceuticals Pricing and reimbursement policy issues Pharmaceutical manufacturing policy and investment issues Supply chain policy issues WTO TRIPS waiver policy issues China outbound investment policy issues US Swiss Trade Agreement US Trade Policy Sec. 232 pharmaceutical tariffs Labor Issues/Antitrust/Workplace: Anti-Trust Reform

Government entities reported: Centers For Medicare and Medicaid Services (CMS) Executive Office of the President (EOP) Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES Office of Management & Budget (OMB) SENATE White House Office Commerce, Dept of (DOC) Patent & Trademark Office (PTO) U.S. Trade Representative (USTR) Congressional Budget Office (CBO) Food & Drug Administration (FDA) Treasury, Dept of

Reported filing-period amount: $1,700,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN

Registrant: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN

4th Quarter (Oct 1 - Dec 31)
Jan 20, 2026

Reported lobbying issue

Budget/Appropriations: H.R.5304/S.2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; a bill to provide for FY2026 appropriations to the Departments of Labor, Health and Human Services, and Education; and related agencies. H.R.4016/S.2572 - Department of Defense Appropriations Act, 2026; a bill to provide for FY2026 appropriations to the Department of Defense (DOD) for military activities. H.R.5371 - Continuing Appropriations and Extensions Act, Agriculture, Leg Branch & Extensions Act; a bill to provide continuing FY2026 appropriations for federal agencies, provides additional funding for security for federal officials, and extends various expiring programs and authorities. FY26 appropriations related to funding for biomedical research, National Breast and Cervical Cancer Early Detection Program, cancer prevention and control, FDA funding workforce and related cancer services Insurance: H.R.3037/S.1500 - Access to Breast Cancer Diagnosis Act; a bill to eliminate cost sharing for medically necessary diagnostic and supplemental breast imaging for patients with private insurance H.R.5813 - Womens Health and Cancer Rights Modernization Act of 2025; a bill to amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to require group health plans and health insurance issuers offering group or individual health insurance coverage to provide coverage of certain items and services relating to breast or chest wall reconstruction furnished in connection with breast cancer treatment. H.R.6182/S.1410 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals at greater risk for breast cancer H.R.6423/S.864 -HELP Copays Act; a bill to amend title XXVII of the Public Health Service Act to apply financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes H.R.4101 - Cancer Drug Parity Act; a bill to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider Implementation of the Affordable Care Act and policies related to the extension of Advanced Enhanced Premium Tax Credits Comments related to the implementation of the Affordable Care Act and H.R.1, the Big Beautiful Bill Act and relevant changes to the ACA Marketplace Comments related to Committee consideration of modernizing care coordination to prevent and treat chronic disease Medicare/Medicaid: H.R.842/S.339 - Medicare Multi-Cancer Early Detection Screening Coverage Act; a bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests H.R.2048/S.3442 - Metastatic Breast Cancer Access to Care Act; a bill to amend title II of the Social Security Act to eliminate the waiting periods for disability insurance benefits and Medicare coverage for individuals with metastatic breast cancer, and for other purposes H.R.6280 - Access to Genetic Counselor Services Act; a bill to amend title XVIII of the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under part B of the Medicare program, and for other purposes. H.R.6182/S.1410 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals at greater risk for breast cancer H.R.6401 - Increasing Medication Access for Seniors Act of 2025; a bill to require the Secretary of Health and Human Services to submit to Congress a report on the option to elect to pay cost-sharing under a prescription drug plan or MA-PD plan in monthly capped amounts Proposed Medicaid waivers, including waivers under Section 1115 of the Social Security Act; policies related to eligibility, continuity of care, and work reporting requirements in Medicaid Activities in support of extending permanent access to telehealth services for Medicare recipients Health Issues: H.R.2381/S.1866 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to reauthorize the National Breast and Cervical Cancer Early Detection Program H.R.4541/S.2339 - The EARLY Act Reauthorization of 2025; a bill To reauthorize the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009. H.Res.806 - Supporting the recognition of October 2025 as National Breast Cancer Awareness Month H.R.6867/S.3564 - Clinical Trial Integrity Act; a bill to direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes

Government entities reported: HOUSE OF REPRESENTATIVES SENATE Health & Human Services, Dept of (HHS) Labor, Dept of (DOL) Treasury, Dept of Centers For Medicare and Medicaid Services (CMS)

Reported filing-period amount: $70,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

SUSAN G. KOMEN

Registrant: ARTEMIS POLICY GROUP LLC

4th Quarter (Oct 1 - Dec 31)
Jan 20, 2026

Reported lobbying issue

Budget/Appropriations: FY26 appropriations for the National Breast and Cervical Cancer Early Detection Program FY26 appropriations for breast cancer research FY26 appropriations for cancer prevention and control Insurance: Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products One Big Beautiful Bill Act (H.R.1) including policies impacting the affordability and accessibility of insurance Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions Letter to House Committee on Ways & Means Health Subcommittee in response to hearing on Modernizing Care Coordination to Prevent and Treat Chronic Disease Medicare/Medicaid: Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act Health Issues: Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies to support National Breast Cancer Awareness Month

Government entities reported: Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES SENATE Centers For Medicare and Medicaid Services (CMS)

Reported filing-period amount: $40,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

Showing the 25 most recent matching disclosures.

Discussion notificationsSign in to subscribe
?
No comments yet. Start the conversation.